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ABSTRACT 
The atom-specific modification has been extensively applied in RNA function and 
structure investigations, catalysis analysis, mechanism studies, as well as therapeutics 
discoveries. Selenium-modified uridine (SeU-RNA) is one of the naturally occurring 
modifications that was discovered in bacterial tRNAs (SeU-RNA) at the wobble position of the 
anticodon loop. Its exact role in the RNA-RNA interaction, especially during the mRNA 
decoding is not completely understood but it was proposed that such Se derivatization on tRNAs 
probably improves the accuracy and efficiency of base-pairing. The wobble base pairs, where U 
in RNA (or T in DNA) pairs with G instead of A, might compromise the high specificity of the 
base pairing. The U/G wobble pairing is ubiquitous in RNA, especially in non-coding RNA. To 
  
assist the research exploration, we have hypothesized to discriminate against U/G wobble pair by 
tailoring the steric and electronic effects at the 2-exo position of uridine base and replacing 2-exo 
oxygen with a selenium atom. This oxygen replacement with selenium offers a unique chemical 
strategy to enhance the base pairing specificity at the atomic level. Here, we report the first 
synthesis of the 2-Se-U-RNAs through synthetic incorporation of 2-Se-uridine (SeU) 
phosphoramidite as well as enzymatic incorporation of 2-Se-uridine triphosphate. Our 
biophysical and structural studies of the SeU-RNAs indicate that this single atom replacement can 
indeed create a novel U/A base pair with higher specificity than the natural one. We reveal that 
the SeU/A pair maintains a structure virtually identical to the native U/A base pair, while 
discriminating against U/G wobble pair. Moreover, we have demonstrated that the synthesized 
SeUTPs (2-Se-UTP and 4-Se-UTP) are stable and recognizable by T7 RNA polymerase. 
Furthermore, the transcribed SeU-hammerhead ribozyme has the similar activity as the 
corresponding native, which suggests usefulness of SeU-RNAs in function and structure studies 
of noncoding RNAs, including the Se-tRNAs. 
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1     GENERAL INTRODUCTION  
1.1 RNA and RNA Modification  
The text of this work has been published as “Atom-specific Mutagenesis of RNAs for 
Structure, Function and Therapeutics Studies”, RNA Nanotechnology and Therapeutics, John 
Wiley & Sons, Inc., 2013, 213-234. I would like to acknowledge Dr. Zhen Huang for his 
intellectual contribution as a co-author. 
Since RNAs are involved in complex biological processes as regulators, their diversities 
in both function and structure have been greatly appreciated.1 RNA possesses not only the ability 
to store genetic information and participate in transcription and translation but also the capacity 
to adopt well-defined three-dimensional structures, which can be readily adjusted to meet various 
functional needs.2 Although the importance of numerous RNAs in catalysis, gene expression, 
protein binding, and therapeutics3 has been acknowledged by the entire scientific society, current 
understanding of RNA function and structure is still limited. Thus, it is not a coincidence that 
RNA modifications have become the subject of very intensive and active research.4 
Over a hundred modified nucleoside residues have been discovered in natural RNAs,5 
including simple methylation, isomerization, and single-atom modification. These modifications 
alter the biophysical and biochemical properties of RNA structure and function. Most of these 
modifications are found in transfer RNAs (tRNA) despite the fact that the precise roles of many 
natural modifications remain mysterious. To synthesize RNAs containing modifications on the 
nucleobases, sugars, and phosphate backbone, both chemical and enzymatic strategies can be 
pursued.6 Modified nucleic acids have tremendous potential for functional and structural 
investigations as well as for drug discovery, especially when equipped with unique properties, 
2 
 
such as enhanced thermal stability,7 nuclease resistance,8 and improved bio-availability.  
1.2 Atom Specific Modification  
Atom-specifically modified or substituted RNAs can offer many unique and novel 
properties without significant perturbation of three-dimensional structures and structural features 
of noncoding RNAs and RNA–protein complexes.9 Hydrogen (H), carbon (C), nitrogen (N), and 
oxygen (O) are the four fundamental organic elements that establish nucleobases and sugars, 
while phosphorus (P) exists in the nucleic acid backbone. These five essential elements 
constitute the frame of nucleic acids. Single-atom replacement (or atom-specific mutagenesis) of 
nucleic acids substitutes one nucleotide atom with another atom from the same element family 
(such as O, S, Se, and Te) or an equivalent atom. Atom-specific mutagenesis of RNA provides 
useful tools to investigate RNA folding, study RNA–RNA and RNA–protein interactions, 
improve biochemical and biophysical properties of RNAs, facilitate gene delivery in RNA 
nanotechnology and drug discovery, and explore potential RNA therapeutics.4, 10  
Among the atom-specific modifications, sulfur and selenium are in the same family with 
oxygen, thereby sharing similar physical and chemical properties, such as atomic radius (O: 0.73 
Å; S: 1.02 Å; Se: 1.16 Å).11 In principle, every oxygen atom on nucleic acids can be replaced by 
sulfur or selenium, and in practice, almost all of the oxygen atoms on the nucleobases, sugar, and 
phosphate backbone have been chemically or enzymatically replaced with sulfur or selenium 
atoms (Figure 1.2.1). This is a great advantage of chalcogen modification in comparison with 
halogen modification (except for fluorine), due to their instability as good leaving groups. In 
general, only the C-5 of pyrimidines, C-8 of purines and C-2 of adenosine are appropriate 
locations for the halogen substitutions. Moreover, the sulfur and selenium modifications have 
been discovered in natural RNAs. Incorporation of the S and Se modifications into 
3 
 
oligonucleotides via synthetic and enzymatic methodologies can help uncover the roles of such 
naturally occurring modifications in order to utilize them in related research area and drug 
discovery. Furthermore, it is noteworthy to mention that the element tellurium, which belongs to 
the chalcogen family with oxygen, sulfur and selenium, but has a much larger size (atomic 
radius: 1.40 Å) and more metallic character, has been introduced into sugar and base moieties of 
DNA.12 The tellurium–DNA demonstrated strong topographic and current peaks through STM 
(Scanning Tunneling Microscope) imaging, which opens a new approach to image nucleic acids 
and their complexes with proteins and small molecule ligands. 
 
Figure 1.2.1. Sulfur and selenium modifications on RNA nucleobases.  
The asterisk (*) indicates naturally occurring compounds. 
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1.2.1 Sulfur Modification 
Sulfur is in the same family with oxygen and is one of the essential elements in 
organisms involved in biological processes. In nature, sulfur-containing nucleobases, including 
2-thiouridine (s2U), 4-thiouridine (s4U) and 2-thiocytidine (s2C), are observed and isolated in 
yeast and Escherichia coli tRNAs as minor components (Figure 1.2.2).13 2-Thionyl modified 
uridine was discovered back in the 1960s and often found with additional modifications at the C-
5-position. These 2-thiouridine derivatives occur at wobble position 34 of E. coli transfer RNA 
(tRNAGlu, tRNALys, and tRNAGln) as well as human tRNALys and are involved in codon–
anticodon interaction during protein translation.14 Biophysical studies showed that the s2U 
exhibits better thermostability, compared to the native one.7, 15 In vitro experiment indicated that 
2-thiouridine derivatives in tRNA prefer A over G at wobble position 34.16 An additional study 
carried out by Ashraf and coworkers shows that the site-specific substitution of 2-thiouridine in 
tRNA has higher affinity in binding to ribosome, compared to unmodified tRNA despite the 
modifications on C-5,17 which has thus highlighted the functional importance of s2U mutation.  
 
Figure 1.2.2. Cloverleaf structure of E. coli tRNAGlu.  
N represents mnm5s2U in E.coli tRNAGlu and mnm5se2U in C. sticklandii seleno-tRNAGlu. 
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1.2.2 Selenium Modification  
Element selenium belongs to chalcogen group in the periodic table together with oxygen 
and sulfur. Although selenium shares similar electronic and chemical properties with oxygen and 
sulfur, their subtle differences determine their distinct applications in biological processes and 
systems. Similar to sulfur, selenium-modified nucleobases are naturally occurring compounds 
that exist in many bacterial tRNAs, such as Escherichia coli, Clostridium sticklandii, 
Methanococcus vannielii, etc..5 The Se modification is often found at the wobble position 
(position 34) of anticodon loop, which is essential for mRNA decoding.18 The seleno nucleobases 
were identified as 2-selenouridine derivatives with modifications on position C-5, such as 5-
aminomethyl, 5-carboxymethylaminomethyl, 5-formyl, and 5-methylaminomethyl functionalities 
(Figure 1.2.2), decades ago. However, the exact role of selenium at position C-2 is not yet clear. 
Since it was hypothesized that the 2-Se functionality discourages the U/G wobble pairing but 
does not affect U/A Watson-Crick base pairing (Figure 2.1.1), the 2-Se functionality is able to 
improve RNA base pair fidelity, thereby enhancing the accuracy of RNA transcription and 
translation. The 2-Se-uridine-containing RNA was chemically synthesized by Huang’s lab to 
further explore the functionality of the seleno modification.9a Consistent with their hypothesis, 
our study showed that with the introduction of selenium at the 2-position, the Se–RNA duplex 
structure is virtually identical to the corresponding native form. The U/G wobble pair was greatly 
discouraged due to the large size of selenium atom and poor electronegativity, which severely 
weakened the hydrogen bonding, while the U/A base pair was not significantly affected. Thus, 
the increased fidelity of U/A base pairing provided new insights into codon–anticodon 
recognition with the seleno modification at the third codon base. Moreover, the 2-selenouridine-
modified hammerhead ribozyme has catalytically activity.19 The Se-modified thymidine at 
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position 420 and guanosine at position 621 in DNA oligonucleotides were also reported recently. 
In addition, the 4-Se-U RNA has been synthesized in the laboratory recently.22 In natural RNA, 
4-selenouridine was reported earlier in E. coli tRNA,23 and the later studies suggested the 4-Se 
functionality as a misincorporation.24 Furthermore, 6-selenoguanine has been applied in 
anticancer therapeutic studies in comparison with 6-thioguanine, and it showed promising 
antitumor activity against L1210 lymphomas, L5178Y lymphomas, and Sarcoma 180,25 while no 
encouraging result was observed yet in the treatment of solid tumors.26 
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2     HIGHER SPECIFICITY OF RNA BASE PAIRING 
2.1 Introduction 
The text of this work has been published as “Novel RNA Base Pair with Higher 
Specificity using Single Selenium Atom”, Nucleic Acids Res., 2012, 40, 5171-5179. I would like 
to acknowledge Dr. Jia Sheng, Dr. Sibo Jiang and Dr. Jianhua Gan for their contribution in RNA 
structure determination as co-authors, and I would like to acknowledge Dr. Zhen Huang and Dr. 
Abdalla E. A. Hassan for their intellectual contribution as co-authors. 
2.1.1 U/G wobble pair 
DNA and RNA are crucial genetic information carriers.27 The base pairs of DNAs (T/A 
and C/G) and RNAs (U/A and C/G) need to be highly specific and accurate for the purpose of 
the precise genetic information storage, replication, transcription and translation. However, the 
wobble base pairs, where U in RNA (or T in DNA) pairs with G instead of A, may compromise 
the high specificity of the base pairing. In RNA, especially non-coding RNA, U/G wobble pair 
(Figure 2.1.1) is ubiquitous28 and sometimes it has the similar stability as the Watson–Crick U/A 
pair.29 U/G wobble pair offers unique structural and thermodynamic features.28-29 On the one 
hand, the U/G pairing increases structure and function diversities of RNA.30 But on the other 
hand, it may jeopardize the pairing specificity and can cause potential mutations in RNA 
transcription and protein translation. Codon–anti- codon mismatch or misreading is observed 
with an error frequency at 10-5 or higher, which may affect the accuracy of synthesized 
proteins.31 For instance, the first position of the codon–anticodon interaction with wobble 
mismatch (U/G) was discovered in Escherichia coli (error frequency = 0.1%) with 100-fold 
higher than the normal error level.31c In this mis-incorporation of serine (codon: AGC),31c glycine 
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codon (GGC) in mRNA is recognized by Ser-charged tRNA (anticodon: GCU) instead of Gly-
charged tRNA (anticodon: GCC). Similarly, the second position of the codon–anticodon 
interaction with wobble mismatch (U/G) was also observed, where Lys (codon: AAA) is mis-
incorporated instead of normal incorporation of Arg (codon: AGA), with much higher error 
frequency (5–12%).32 To avoid the negative impact of the wobble pairing on the level of protein 
synthesis, the genetic codes with degeneracy are used to deal with the consequence of the wobble 
pairing. Thus, wobble pairing is often observed at the third codon position through the codon 
degeneracy to limit errors. However, the codons forming the Watson–Crick pairs with tRNA 
anticodons are still preferred.33 Study shows that the third codon position with a Watson–Crick 
base pair can reduce the frequency of amino acid mis-incorporation by nearly 10-fold, and it is 
much more accurate than that with a wobble pair for the same amino acid.34 Nevertheless, the 3-
nt genetic codes that accommodate the wobble pairing are used as the most ideal counter- 
measure at the level of protein synthesis in living organisms.35 Clearly, on the basis of the 
chemical principle, this degeneracy strategy properly guarantees the translation accuracy at the 
protein level by tolerating wobble pairs and silent mutations at the RNA and DNA levels. 
 
Figure 2.1.1. Native and Se-modified U/A pairs and U/G wobble pairs. 
Selenium substitution for the oxygen atom was labeled in red.  
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2.1.2 Sulfur- and selenium-modified wobble pair 
Since the 2-exo-oxygen of uridine plays a significant role in U/G wobble pair, we hypothesized 
that tailoring the steric and electronic effects at this site may discriminate against the wobble 
pair, enabling the modified U/A base pair with higher specificity. Interestingly, selenium has 
been discovered in natural tRNAs in the 2-Se-uridine form, i.e. 5-methylaminomethyl-2-
selenouridine (mnm5se2U), in the wobble position on the anticodon loop.18, 24 The function of 
such selenium modification is not completely clear yet, though it was proposed that such Se 
derivatization on tRNAs probably improves the accuracy and efficiency of protein translation.36 
Similarly, the corresponding sulfur modification has been observed on natural tRNAs.37 Sulfur 
was chemically introduced to the 2-position of uridine.38 The S-modified U/G pair is slightly less 
stable than the native U/G pair,29b while the SU/A is more stable over the native U/A pair. Thus, 
we hypothesized that the 2-oxygen replacement with selenium (SeU, Figure 2.1.1) can destabilize 
and discriminate against the U/G wobble pair, because the atomic size of selenium (1.16 Å) is 
larger than that of sulfur (1.02 Å) and oxygen (0.73 Å). Moreover, selenium has the least ability 
to form a hydrogen bond among O, S and Se, which weakens the hydrogen bond originally 
formed by the 2-oxygen of the wobble pair. Thus, it is expected that this 2-Se-replacement can 
largely destabilize U/G pair by generating a steric hindrance against the pair and significantly 
weakening the hydrogen bond. Furthermore, it is expected that the 2-Se-substitution does not 
significantly affect the hydrogen bonds within the U/A pair, since the 2-oxygen is not directly 
involved in the U/A base pairing. Therefore, we decided to incorporate selenium into the 2-
position of uridine in RNA, in order to atom-specifically increase the U/A pair specificity and 
disrupt the U/G wobble. 
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2.2 General Experimental Section 
2.2.1 Synthesis of 2-Se-uridine phosphoramidite  
Though selenium was incorporated into uridine four decades ago,39 RNA containing 2-
Se-uridine (SeU) hasn’t been synthesized because of the synthetic challenge. Recently our 
laboratory has successfully developed a novel strategy to incorporate the selenium functionality 
to the 2-position of thymidine in DNA.40 This successful strategy has encouraged us to introduce 
the selenium functionality to the 2-position of uridine in RNA. Herein we report the first 
synthesis of the 2-selenouridine derivatives and RNAs. The synthesis (Scheme 2.2.1) started 
from the glycosidation of 1 with silylated 2-thiouracil (3), followed by benzoyl deprotection and 
trityl protection of the 5’-hyroxyl group to offer 6.41 After methylation of 6 to activate the 2-thio-
functionality,40 NaSeH was used to displace the 2-S-functionality and offer the 2-Se-uridine (8) 
in 85% yield. Following the protections of the 2’-hydroxyl group and the 2-Se-functionality with 
ICH2CH2CN, the Se-phosphoramidite (11) was synthesized by phosphitylation of 10a.40, 42  The 
SeU-phosphoramidite was finally incorporated into RNAs by solid-phase synthesis. The 
synthesized SeU-RNAs (12) were deprotected, purified, and confirmed by HPLC and MS (Figure 
2.2.3,Table 2.2.1). For the purpose of comparison, the corresponding S-modified RNA was also 
synthesized by following the literature41 and characterized by HPLC and MS analyses (Table 
2.2.1, Figure 2.2.3). 
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Scheme 2.2.1. Synthesis of 2-Se-Uridine containing RNA. 
Reagents and conditions: a) TMS-Cl, HMDS, reflux; b) SnCl4, C2H4Cl2, -20oC; c) NaOCH3, 
MeOH; d) DMTr-Cl, pyridine, rt. (e) CH3I, DBU, DMF; (f) Se, NaBH4, EtOH; (g) TBDMS-Cl, 
imidazole, DMF; (h) ICH2CH2CN, (i-Pr)2NEt, CH2Cl2; (i) (i-Pr2N)2P(Cl)OCH2CH2CN, (i-
Pr)2NEt, CH2Cl2; (j) solid-phase synthesis. 
 
2.2.1.1 Synthesis of compound 4 
1-(2’,3’,5’-tri-O-benzoyl-beta-D-ribofuranosyl)-2-thiouridine (Compound 4). 
4-[(trimethylsilyl)oxy]-2-[(trimethylsilyl)thio]-pyrimidine 2 was synthesized7, 43 by the 
silylation of 2-thiouracil 1 (3.81 g, 29.76 mmol) with hexamethyldisilazane (HMDS, 100 mL) 
and catalytic amount of trimethylsilyl chloride (TMSCl, 0.5 mL) under reflux condition 
overnight until a clear yellow solution was obtained. The excess of HMDS and TMSCl was 
evaporated under reduced pressure. 1-O-Acetyl-2,3,5-tri-O-benzoyl-bata-D-ribofuranose 3 (10 g, 
19.82 mmol) was dissolved in 1,2-dichloroethane (99 mL), then it was added to the concentrated 
silylated 2-thiouracil 2. Tin (IV) chloride (6.9 mL) was subsequently added at -20 oC under 
nitrogen. The reaction was stirred for 5 hours and poured into a saturated aqueous sodium 
bicarbonate solution with stirring. After 1 hour, the suspension was extracted with 
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dichloromethane (6x50 mL). The organic layers were combined and dried over anhydrous 
magnesium sulfate, followed by filtration and evaporation under reduced pressure. The crude 
compound was purified by column chromatography (1% methanol in dichloromethane), offering 
4 as a white foam (10.5 g, 85% yield). The compound was analyzed by 1H NMR and its chemical 
shifts were consistent with the known compound44. 1H NMR (400 MHz, CDCl3) δ 10.30 (s, 1H, 
NH), 8.13 – 8.05 (m, 2H, Ar), 8.05 – 7.97 (m, 2H, Ar), 7.96 – 7.89 (m, 2H, Ar), 7.70 (d, J = 8.2 
Hz, 1H, H-6), 7.65 – 7.49 (m, 5H, Ar), 7.43 – 7.35 (m, 4H, Ar), 7.28 (d, J = 4.7 Hz, 1H, H-1’), 
5.84 – 5.76 (m, 3H, H-5, H-2’,H-3’), 4.88 (dd, J = 12.6, 2.5 Hz, 1H, H-5’), 4.78 (dt, J = 5.3, 2.8 
Hz, 1H, H-4’), 4.69 (dd, J = 12.6, 3.1 Hz, 1H, H-5’). 
 
2.2.1.2 Synthesis of compound 5 
2-thio-1-beta-D-ribofuranosylpyrimidine-2,4-dione (Compound 5). 
Compound 4 (10.5 g, 18.35 mmol) was dissolved in methanol (92 mL) and sodium 
methoxide (5.95 g, 0.11 mol) was added to the solution. After stirring for 6 hours, the solution 
was neutralized by adding DOWEX 50WX8-400 ion-exchange resin (H+-form, approximately 
110 meq until neutral, monitored by moisturized pH paper) washed with methanol. The mixture 
was filtered and methanol was evaporated. The residue was suspended with water (100 mL) and 
extracted with ethyl acetate (2x30 mL). Water layer was lyophilized (or evaporated under 
reduced pressure) to give deprotected nucleoside 5. The crude product was monitored by TLC 
plate (20% methanol in dichloromethane, Rf = 0.4) to confirm the removal of the by-product, 
methyl benzoate. The crude product was purified by recrystallization in ethanol and gave a white 
powder. The compound was analyzed by 1H NMR and its chemical shifts were consistent with 
the known compound (Ref. 1,2). 1H NMR (D2O) δ: 8.15 (d, J = 8.2 Hz, 1H, H-6), 6.64 (d, J = 
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2.4 Hz, 1H, H-1’), 6.20 (d, J = 8.2 Hz, 1H, H-5), H-4’ overlap with HOD signal, 4.41 (m, 1H, H-
3’), 4.22 (d, J = 2.4 Hz, H-2’), 4.04 -3.89 (m, 2H, H-5’). 
 
2.2.1.3 Synthesis of compound 6 
1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-thiouridine (Compound 6). 
2-thiouridine 5 (3 g, 11.54 mmol) and 4, 4’-dimethoxytrityl chloride (DMTr-Cl, 4.69 g, 
13.85 mmol) were dried individually under high vacuum. A solution of DMTr-Cl dissolved in 
anhydrous pyridine (15 mL) was slowly added to 5 dissolved in anhydrous pyridine (40 mL) 
under nitrogen gas, at 0 oC. The mixture was stirred for three hours at room temperature and 
methanol (5 mL) was then added to the mixture to quench the reaction. Pyridine was evaporated 
under reduced pressure and co-evaporated with toluene (20 mL) for 3 to 4 times. The residue 
was dissolved with ethyl acetate (30 mL) and washed with water twice (20 mL). The organic 
phase was dried over anhydrous magnesium sulfate, filtered and evaporated to dryness. 
Purification was carried out by flash column chromatography (2% methanol in dichloromethane) 
pre-equalized by 1% triethylamine in dichloromethane before sample loaded. Compound 6, a 
yellow form was obtained (5 g, 80% yield; 31). 1H NMR (CDCl3) δ: 11.02 (s, 1H, NH), 8.23 (d, 
J = 8.2 Hz, 1H, H-6), 7.44 – 7.13 (m, 9H, Ar), 6.83 (m,  4H, Ar), 6.43 (s, 1H, H-1’), 5.55 (d, J = 
8.2 Hz, 1H, H-5), 4.50 (m, 1H, H-4’), 4.43 (m, 1H, H-3’), 4.35 (s, 1H, OH), 4.19 (d, J = 7.4 Hz, 
1H, H-2’), 3.75 (d, J = 1.7 Hz, 6H, OCH3), 3.56 (dd, J = 20.8, 9.5 Hz, 2H, H-5’), 3.41 (br, 1H, 
OH); 13C NMR (CDCl3) δ: 175.32 (C-2), 160.70 (C-4), 158.79 (Ar), 144.43 (Ar), 141.08 (C-6), 
135.37 (Ar), 135.15 (Ar), 130.30 (Ar), 130.22 (Ar), 128.25 (Ar), 128.19 (Ar), 127.33 (Ar), 
113.48 (Ar), 106.75 (C-5), 94.37 (C-1’), 87.22 (C-Ar3), 83.78 (C-4’), 75.80 (C-2’) , 69.17 (C-3’) 
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, 61.21 (C-5’), 55.40 (OCH3); HRMS (ESI-TOF) [M-H+]- = 561.1718 (calc. 561.1695), Chemical 
Formula: C30H29N2O7S. 
 
2.2.1.4 Synthesis of compound 7 
1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-methylthiouridine (Compound 7). 
Dry compound 6 (5 g, 8.89 mmol) was dissolved in dry N, N-dimethylformamide (DMF), 
followed by addition of iodomethane (5.5 mL, 89 mmol). 1,8-diazabicyclo[5.4.0]undec-7-ene (2 
mL, 13.3 mmol) was then added to the reaction mixture at 0 oC. The reaction was monitored by 
TLC plate (12% methanol in dichloromethane, Rf = 0.4) and completed in 4 hours. Ethyl acetate 
(50 mL) was poured into the mixture and DMF was removed by washing the organic layer with 
saturated sodium chloride solution. The organic phase was dried over anhydrous magnesium 
sulfate and evaporated under reduced pressure. The residue was purified by flash column 
chromatography (10% methanol in dichloromethane) and pure compound 7 was obtained in 95% 
yield. 1H NMR (CDCl3) δ: 7.87 (d, J = 7.7 Hz, 1H, H-6), 7.44-7.20 (m, 9H, Ar), 6.85 (m, 4H, 
Ar), 6.11 (br, 1H, OH), 5.88 (d, J = 6.0 Hz, 1H, H-1’), 5.54 (d, J = 7.7 Hz, 1H, H-5), 4.63 (m, 
1H, H-4’), 4.44 (m, 1H, H-3’), 4.24 (d, J = 2.3 Hz, 1H, H-2’), 3.75 (d, J = 3.1 Hz, 6H, OCH3), 
3.42 (m, 2H, H-5’), 3.40 – 3.30 (br, 1H, OH), 2.55 (s, 3H, SCH3); 13C NMR (CDCl3) δ: 169.19 
(C-4), 164.36 (C-2), 158.88 (Ar), 144.49 (Ar), 140.13 (C-6), 135.37 (Ar), 135.22 (Ar), 130.41 
(Ar), 130.28 (Ar), 128.32 (Ar), 128.28 (Ar), 127.29 (Ar), 113.54 (Ar), 108.92 (C-5), 91.95 (C-
1’), 87.35 (C-Ar3), 84.82 (C-4’), 75.24 (C-2’), 71.63 (C-3’), 63.40 (C-5’), 55.40 (OCH3), 15.39 
(SCH3); HRMS (ESI-TOF) [M+H+]+ = 577.2003 (calc. 577.2008), Chemical Formula: 
C31H33N2O7S. 
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2.2.1.5 Synthesis of compound 8 
1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-selenouridine (Compound 8). 
A solution of NaSeH was generated by addition of absolute ethanol (50 mL) to selenium 
(6.2 g, 78 mmol) and sodium borohydride (NaBH4, 4.43 g, 0.117 mol) at 0 oC. The reaction was 
completed in two hours and a clear solution was formed. The ethanolic solution was added to 
compound 7 (4.5 g, 7.80 mmol) and the mixture was stirred for eight hours under argon. The 
reaction mixture was then concentrated under reduced pressure and ethyl acetate (50 mL) was 
added to the residue. The organic layer was washed with water several times (5x30 mL), and 
then dried over anhydrous magnesium sulfate. Purification was performed by flash column 
chromatography (4% methanol in dichloromethane) and the light yellow compound (8) was 
obtained (85% yield). 1H NMR (CDCl3) δ: 10.95 (s, 1H, NH), 8.24 (d, J = 8.2 Hz, 1H, H-6), 7.44 
– 7.19 (m, 9H, Ar), 6.84 (m, 4H, Ar), 6.48 (s, 1H, H-1’), 5.66 (d, J = 8.1 Hz, 1H, H-5), 4.48 (m, 
2H, H-4’,H-3’), 4.22 (m, 1H, H-2’), 3.89 (s, 1H, OH), 3.79 (s, 6H, OCH3), 3.58 (dd, J = 23.6, 9.2 
Hz, 2H, H-5’), 2.97 (br, 1H, OH); 13C NMR (CDCl3) δ: 175.74 (C-2), 159.21 (C-4), 158.98 (Ar), 
158.94 (Ar), 144.45 (Ar), 140.82 (C-6), 135.38 (Ar), 135.18 (Ar), 130.35 (Ar), 130.27 (Ar), 
128.30 (Ar), 128.28 (Ar), 127.45 (Ar), 113.58 (Ar), 108.37 (C-5), 96.86 (C-1’), 87.38 (C-Ar3), 
84.41 (C-4’), 76.33 (C-2’), 69.19 (C-3’), 61.20 (C-5’), 55.48 (OCH3). HRMS (ESI-TOF) [M-H+]-
=609.1136 (calc. 609.1140), Chemical Formula: C30H29N2O7Se; UV (MeOH): λmax = 311 nm (in 
methanol). 
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2.2.1.6 Synthesis of compound 9 
1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-
selenouridine (Compound 9a) and 1-(3’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-
beta-D-ribofuranosyl)-2-selenouridine (Compound 9b). 
5’-DMTr-2-selenouridine 8 (0.5 g, 0.82 mmol) was dissolved in dry N,N-
dimethylformamide, then tert-butyldimethylsilyl chloride (TBDMSCl, 0.15 g, 0.98 mmol) and 
imidazole (0.11 g, 1.64 mmol) were added into the solution under nitrogen gas. The reaction was 
monitored by TLC plate (15% ethyl acetate in dichloromethane, Rf = 0.8). The mixture was 
stirred overnight at room temperature and then directly poured into ethyl acetate (20 mL) and 
washed with water (2x20 mL). The organic layer was dried by anhydrous magnesium sulfate and 
evaporated under reduced pressure. Two compounds, 9a and 9b, were obtained. The two 
regional isomers (ratio 1:1) were purified together by flash column chromatography (10% ethyl 
acetate in dichloromethane) and were not further separated. Since it was both challenging and 
unnecessary to separate each isomer, we decided to move to the next step of synthesis without 
separation of these two isomers. HR-MS (ESI-TOF, 9a and 9b) [M-H+]- = 723.1990 (calc. 
723.2005). Chemical Formula: C36H43N2O7SeSi. 
2.2.1.7 Synthesis of compound 10 
1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-
cyanoethylselanyluridine (Compound 10a) and 1-(3’-O-tert-butyldimethylsilyl-5’-O-4,4’-
dimethoxytrityl-beta-D-ribofuranosyl)-2-cyanoethylselanyluridine (Compound 10b). 
The mixture (0.52 g, 0.72 mmol) of 9a and 9b was dissolved in dried dichloromethane at 
0oC. Iodopropionitrile (0.78 g, 4.31 mmol) was added to the solution, followed by addition of 
diisopropylethylamine (0.37 mL, 2.15 mmol). The reaction was monitored by TLC plates (30% 
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Ethyl acetate in dichloromethane). After 4 hrs reaction, the solvent was removed under reduced 
pressure and the residue was partitioned between ethyl acetate (20 mL) and water (20 mL). The 
organic phase was dried over anhydrous magnesium sulfate and evaporated into dryness. Two 
crude products were obtained: 1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-D-
ribofuranosyl)-2-cyanoethylselanyluridine 10a (Rf = 0.35) and 1-(3’-O-tert-butyldimethylsilyl-
5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-cyanoethylselanyluridine 10b (Rf = 0.30). 
These two compounds can be separated by flash column chromatography (15% ethyl acetate in 
dichloromethane). 10a was obtained in 0.228 g (41% yield) and 10b was obtained in 0.235 g 
(42% yield). 10a: 1H NMR (CDCl3) δ: 7.96 (d, J = 7.7 Hz, 1H, H-6), 7.53 – 7.11 (m, 9H, Ar), 
6.85 (m, 4H, Ar), 5.71 (d, J = 7.7 Hz, 1H, H-5), 5.60 (d, J = 6.5 Hz, 1H, H-1’), 4.61 – 4.49 (m, 
1H, H-4’), 4.31 (m, 2H, H-3’, H-2’), 3.80 (s, 6H, OCH3), 3.54 – 3.34 (m, 4H,H-5’, 
SeCH2CH2CN), 3.01 (m, 2H, SeCH2CH2CN), 2.91 (s, 1H, OH), 0.94 (s, 9H, SiCMe3), 0.09 (d, 
6H, SiMe2); 13C NMR (CDCl3) δ: 167.70 (C-4), 159.04 (C-2), 158.51 (Ar), 144.17 (Ar), 139.19 
(C-6), 134.91 (Ar), 134.74 (Ar), 130.26 (Ar), 130.17 (Ar), 128.30 (Ar), 128.11 (Ar), 127.58 (Ar), 
118.78 (CN), 113.58 (Ar), 110.61 (C-5), 93.13 (C-1’), 87.82 (C-Ar3), 85.39 (C-4’), 77.27 (C-2’), 
72.40 (C-3’), 63.82 (C-5’), 55.44 (OCH3), 25.84 (SiCMe3), 24.06 (SeCH2CH2CN), 18.89 
(SeCH2CH2CN), 18.14 (SiCMe3), -4.56 (SiCH3)., -4.91 (SiCH3). HRMS (ESI-TOF) [M+H+]+ = 
778.2464 (calc. 778.2427). Chemical Formula: C39H48N3O7SeSi. 10b: 1H NMR (CDCl3) δ: 8.09 
(d, J = 7.7 Hz, 1H, H-6), 7.32 (m, 9H, Ar), 6.88 (m, 4H, Ar), 5.75 (d, J = 7.7 Hz, 1H, H-5), 5.65 
(d, J = 3.7 Hz, 1H, H-1’), 4.46 (m, 1H, H-2’), 4.21 (dd, J = 9.3, 5.1 Hz, 1H, H-4’), 4.18 – 4.08 
(m, 1H, H-3’), 3.83 (s, 6H, OCH3), 3.70 (m, 1H, H-5’), 3.55 (m, 1H, H-5’), 3.41 (m, 2H, 
SeCH2CH2CN), 3.22 (d, J = 5.5 Hz, 1H, OH), 3.08 (m, 2H, SeCH2CH2CN), 0.90 (s, 9H, 
SiCMe3), 0.11 (d, 6H, SiMe2). 13C NMR (CDCl3) δ: 167.90 (C-4), 159.05 (C-2), 157.82 (Ar), 
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143.99 (Ar), 138.96 (C-6), 135.02 (Ar), 134.89 (Ar), 130.35 (Ar), 130.34 (Ar), 128.37 (Ar), 
128.29 (Ar), 127.58 (Ar), 118.95 (CN), 113.56 (Ar), 113.53 (Ar), 110.49 (C-5), 93.84 (C-1’), 
87.57 (C-Ar3), 84.72 (C-4’), 76.17 (C-2’), 71.05 (C-3’), 61.71 (C-5’), 55.48 (OCH3), 25.82 
(SiCMe3), 24.12 (SeCH2CH2CN), 18.92 (SeCH2CH2CN), 18.17 (SiCMe3), -4.59 (SiCH3), -4.60 
(SiCH3). HRMS (ESI-TOF) [M+H+]+ = 778.2401 (calc. 778.2427). Chemical Formula: 
C39H48N3O7SeSi. 
2.2.1.8 Synthesis of compound 11 
1-[2’-O-tert-butyldimethylsilyl-3’-O-(2-cyanoethyl-N,N-diisopropylamino) 
phosphoramidite-5’-O-(4,4’-dimethoxytrityl-beta-D-ribofuranosyl)]-2-cyanoethylselanyluridine 
(Compound 11). 
Diisopropylethylamine (15.5 mg, 0.12 mmol) and 2-cyanoethyl N,N-
diisopropylchlorophosphoramidite (26 mg, 0.11 mmol) were added to a solution of 10a (100 mg, 
0.10 mmol) in dry dichloromethane (5 mL) at room temperature under nitrogen gas. The mixture 
was monitored by TLC (15% ethyl acetate in dichloromethane). When the reaction was 
completed in 4 hrs, rapid Al2O3 column chromatography (dichloromethane as the eluent) was 
performed to remove the organic salts. The solvent was then evaporated under reduced pressure 
and the residue was dissolved in 0.5 mL dichloromethane and precipitated in dry hexane under 
vigorous stirring. The precipitate was collected by filtration, dried under reduced pressure and 
directly used for solid phase synthesis. 1H NMR (CDCl3) δ: 7.95 (d, J = 7.7 Hz, 1H, H-6), 7.30 
(m, 9H, Ar), 6.84 (m,4H, Ar), 5.82 (d, J = 7.6 Hz, 1H, H-1’), 5.63 (d, J = 7.7 Hz, 1H, H-5), 4.68 
– 4.43 (m, 1H, H-4’), 4.43 – 4.29 (m, 1H, ), 4.24 (s, 1H), 3.98 (dd, J = 15.6, 8.4 Hz, 2H), 3.80 (s, 
6H, OCH3), 3.63 (dd, J = 19.8, 7.3 Hz, 4H), 3.42 (dd, J = 19.3, 8.7 Hz, 5H), 3.01 (s, 2H), 2.70 
(d, J = 5.8 Hz, 2H), 1.20 (d, J = 6.7 Hz, 18H), 1.08 (d, J = 6.5 Hz, 6H), 0.92 (s, 13H), 0.14 – 0.02 
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(m, 9H); 13C NMR (CDCl3) δ: 167.83 (C-4), 159.04 (C-2), 158.71 (Ar), 144.16 (Ar), 139.02 
(Ar), 134.96 (Ar), 134.74 (Ar), 130.21 (Ar), 130.14 (Ar), 128.38 (Ar), 128.04 (Ar), 127.58 (Ar), 
118.86 (SeCH2CH2CN),  117.75 (OCH2CH2CN), 113.67 (Ar), 110.69 (C-5), 92.50 (C-1’) , 87.92 
(C-Ar3), 85.43 (C-4’), 77.15 (C-2’), 72.81 (C-3’), 63.72 (C-5’), 59.39 (OCH2CH2CN), 55.48 
(OCH3), 43.22-43.10 (NCMe2), 29.90 (OCH2CH2CN), 26.12-25.97 (NCMe2), 24.85 (SiCMe3), 
24.02 (SeCH2CH2CN), 18.94 (SeCH2CH2CN), 18.37 (SiCMe3),-4.35 (SiCH3), -4.56 (SiCH3); 31P 
NMR (CDCl3) δ: 148.81, 152.30. HRMS (ESI-TOF) [M+H+]+ = 978.3528 (calc. 978.3505). 
Chemical Formula: C48H65N5O8PSeSi. 
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2.2.2 Solid phase synthesis of the 2-Se-functionalized RNAs 
 
Figure 2.2.1. Oligonucleotide solid phase synthesis cycle. 
 
ABI3400 DNA/RNA Synthesizer was used for all the RNA oligonucleotides synthesis 
(1.0 µmol scale). All the non-modified nucleoside phosphoramidite reagents used were ultra-
mild (Glen Research). The synthetic cycle is a stepwise addition of nucleoside phosphoramidite 
to the 5’ side of the nucleotide chain. It starts from detritylation of 5’-DMTr of the solid support 
bounded oligonucleotide to free the hydroxyl group. Then the nucleoside phosphoramidite is 
delivered to couple with the solid support bounded oligonucleotide in a solution of azole catalyst. 
After coupling, the unreacted 5’-OH group is blocked with a capping mixture to prevent further 
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elongation reactions. To stabilize the phosphite trimester linkage, the oxidation step is carried out 
to transform it to a pentavalent phosphate with iodine, and then the solid support bounded 
oligonucleotide ready for the new addition of next nucleobase (Figure 2.2.1). 
RNA oligonucleotides were synthesized in DMTr-on form, cleaved from the beads and 
deprotected by the treatment of 0.05 M K2CO3 methanol solution for 10 hours at room 
temperature. After evaporating the solution to dryness, the 2’-TBDMS deprotection was 
performed in TBAF (0.5 mL, 1 M) for 14 hours at room temperature. Then the RNAs were 
treated with 1 M Tris-HCl buffer (0.5 mL, pH 7.5) for 5 min, followed by concentrating to 0.5 
mL and desalting using G-25 Sephadex column. The 5’-DMTr deprotection was then performed 
using Glen-Pek RNA column, followed by desalting using Sep-Pak Vas column. 
2.2.3 pH titration curve of 2-selenouridine 
 
Figure 2.2.2. Plot of wavelength (nm) versus pH for 2-selenouridine nucleoside.  
 
2-Selenouridine was prepared through detritylation of 1-(5’-O-4,4’-dimethoxytrityl-b-D-
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ribofuranosyl)-2-selenour idine (8) by acid treatment. The 2-selenouridine solutions were 
adjusted to desired pH values in the buffer of 50 mM Na2HPO4 at room temperature. The UV–
Vis spectra were recorded every 0.1 pH unit between pH 6–8 and every 0.2-0.5 pH unit between 
pH 4–6 and pH 8–10. The pH of each solution was measured before and after its UV–Vis 
spectrum collection and the error was within ±0.02 pH unit. The titration data was plotted and 
shown in Figure 2.2.2. 
2.2.4 HPLC analysis and purification 
 
Table 2.2.1. MALDI-TOF MS of 2-Se-U RNAs 
 
The RNA oligonucleotides were analyzed and purified by reversed-phase high 
performance liquid chromatography (RP-HPLC), flow rate 6 mL/min [Buffer A: 20 mM 
triethylammonium acetate (TEAAc, pH 7.1) in water; buffer B: 20 mM TEAAc (pH 7.1) in 50% 
acetonitrile]. The HPLC analysis was performed with a linear gradient from buffer A to 100% 
buffer B in 20 min. Native RNAs were purchased from Integrated DNA Technologies. The 
concentrations of the native, S- and Se-modified RNAs were adjusted to 1.0 mM in water. The 
S- and Se-RNA samples were characterized by MALDI-TOF MS (Table 2.2.1) and HPLC 
(Figure 2.2.3).  
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Figure 2.2.3. HPLC analysis and purification of 2-S-U and 2-Se-U Modified RNAs.  
(A) The HPLC analysis profile of crude DMTr-on Se-RNA (5’-rAUCACCSeUCCUUA-3’) after 
cleavage from solid support and deprotection steps. The DMTr-on Se-RNA retention time was 
12.2 min. (B) The HPLC analysis profile of pure DMTr-off Se-RNA (5’-rAUCACCSeUCCUUA-
3’) with same gradient and buffer. The DMTr-off Se-RNA retention time was 7.1 min. (C) The 
HPLC analysis profile of pure DMTr-off Native-RNA (5’-rAUCACCUCCUUA-3’). The DMTr-
off Native-RNA retention time was 10.0 min. (D) The HPLC analysis profile of pure DMTr-off 
S-RNA (5’-rAUCACCSUCCUUA-3’) with same gradient and buffer. The DMTr-off S-RNA 
retention time was 10.4 min. Samples were eluted with a linear gradient from buffer A (20 mM 
triethylammonium acetate, pH 7.1) to 70% buffer B (50% acetonitrile, 20 mM 
triethylammonium acetate, pH 7.1) in 10 min, to 100% buffer B in 12 min and continuous 100% 
buffer B to 20 min. 
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2.2.5 Thermodenaturization of duplex RNAs 
 
Table 2.2.2. Melting temperatures (Tm) of the native, S- and Se-modified RNA duplexes. 
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Table 2.2.3. Melting temperatures of native and 2-Se-U RNA modified duplexes (5’- 
rAAUGCUGCACUG -3’). 
ΔTm1 refers to the Tm difference between the native U/A pair and the other mis-pairs (U/G, U/C 
and U/U), and ΔTm2 refers to the Tm difference between the SeU/A pair and the other modified 
mis-pairs (SeU/G, SeU/C and SeU/U). 
 
UV-melting temperatures (Tm) of the native, S- and Se- modified duplexes with match 
and mismatch sequences are shown in Table 2.2.2, Table 2.2.3 and Figure 2.2.6. Tm of the Se-
RNA duplex containing the SeU/A Watson-Crick pair was 2.4 or 3.0 oC higher than those of the 
corresponding duplexes containing native U/A pair (Table 2.2.2, Figure 2.2.6). Comparing with 
native U/G, the SeU/G pair is approximately 4 oC less stable than the native formation. While the 
SeU/C mis-pair is slightly less stable than the U/G pair, suggesting that SeU discourages the SeU/G 
pair native U/C mis-pair, the SeU/U mis-pair is more stable than the native U/U mis-pair. The 
higher stability may be attributed to the higher acidity of the imino group (3-NH) of SeU [pKa = 
7.29 ± 0.02, Figure 2.2.2, compared to that of the native uridine (pKa = 9.18 ± 0.02)45], which 
may promote U/U inter- action via hydrogen bond. In addition, considering a selenium atom is 
0.43 Å larger in atomic radius than an oxygen atom, the 2-Se atom may strengthen the stacking 
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interaction between SeU and its 3’-nucleobase (Figure 2.2.4).  
 
Figure 2.2.4. Local structures of the native RNA and SeU-containing RNA r[5’-
GUAUA(SeU)AC-3’]2 with a resolution of 2.3 Å.  
The 2-position atom (oxygen or selenium) of U6 stacks with A7. (A) The native 5’-U6-A7-3’ 
local structure; (B) the native 5’- SeU6-A7-3’ local structure. A selenium atom is 0.43 Å larger in 
atomic radius than an oxygen atom. 
 
When directly comparing the Watson-Crick base pairs (U/A and SeU/A) with their own 
corresponding mis-pairs, it is clear that SeU/A pair has the balanced discrimination against all 
mis-pairs, with the Tm differences of SeU/G (7.3 oC in Figure 2.2.5 and 11.0 oC in Table 2.2.3), 
SeU/C (15.5 oC), and SeU/U (8.5 oC). On the other hand, the native U/A pair has poor 
discrimination against U/G wobble pair (the Tm differences: 0.3 oC in Figure 2.2.5 and 4.7 oC in 
Table 2.2.3), while maintaining fine discrimination against U/C (12.2 oC) and U/U (14 oC) pairs. 
Therefore, in general, SeU/A has higher base pair fidelity than the native U/A pair. When 
comparing the SeU/A with the corresponding SU/A pair, the same statement is also true (Figure 
2.2.5). Furthermore, the Tm difference (8.5 oC) of SeU/A and SeU/U is bigger than the Tm 
difference (5.8 oC) of SU/A and SU/U, thus the SeU/A can better discriminate against SeU/U mis-
pair than the SU/A against SU/U mis-pair. In general, SeU/A can better discriminate against all 
27 
 
corresponding mis-pairs than SU/A, thereby SeU/A offering higher base pair fidelity than SU/A. 
 
Figure 2.2.5. Differences of melting temperatures (Tm) of the native, S- and Se-modified U/A 
pairs and their corresponding mis-pairs.  
O (white bar) refers to the Tm difference between the native U/A pair and the other mis-pairs 
(U/G, U/C and U/U); S (grey bar) refers to the Tm difference between the SU/A pair and the 
other modified mis-pairs (SU/G, SU/C and SU/U); Se (black bar) refers to the Tm difference 
between the SeU/A pair and the other modified mis-pairs (SeU/G, SeU/C and SeU/U). 
 
As hypothesized, the 2-Se-functionality on uridine can indeed largely increase the base 
pairing specificity of RNA by discriminating against U/G wobble pairing. The Tm differences 
between the native U/A pair and U/G wobble pair were relatively small (4.7 oC in Figure 2 and 
0.3 oC in Figure 2.2.6). The small Tm differences indicate possible changes between U/A and 
U/G pairs without a significant decrease in duplex stability. This is consistent with the ubiquitous 
presence of U/G wobble pair in RNAs, which diversifies the structure and function of RNAs, 
especially non-coding RNAs. Such small thermostability difference between native U/A pair and 
U/G wobble pair has been previously observed in the literature.29a Interestingly, the Tm 
differences between the SeU/A and SeU/G pairs were significant, such as 7.3 oC (vs 0.3 oC in the 
native) in Figure 2 and 11 oC (vs 4.7 oC in the native) in Table 2.2.3. The SeU modification in 
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RNA duplexes directly decreases the thermal stability of the U/G wobble pair by 4.0 oC (Table 
2.2.2) and 3.9 oC (Table 2.2.3). This experimental observation reveals that the U/G wobble pair 
is greatly discriminated by incorporating a selenium atom to the 2 position of uridine. The strong 
discrimination against U/G pair is mainly attributed to the selenium disruption of the hydrogen 
bond formed by the 2-oxygen (Figure 2.1.1) and to the steric effect of the bulky selenium atom at 
the 2-position. Clearly, our results indicate that the 2-Se-modification on uridine significantly 
increases the high specificity of the U/A base pair. 
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Figure 2.2.6. Normalized UV-melting curves of RNA duplexes.  
(A) Native RNA (5’-rAUCACCUCCUUA-3’) paired with matched and mismatched strands; (B) 
Modified RNA (5’-rAUCACCSeUCCUUA-3’) with matched and mismatched strands. (C) Native 
RNA (5'-rAAUGCUGCACUG-3') paired with matched and mismatched strands; (D) Modified 
RNA (5'-rAAUGCSeUGCACUG-3') with matched and mismatched strands. 
2.2.6 Crystallization and data collection of Se-RNA 
Perfluoropolyether was used as a cryoprotectant during the crystal mounting, and data 
collection was taken under the liquid nitrogen stream at 99°K. The Se-RNA crystal data were 
collected at beam line X12B and X12C in NSLS of Brookhaven National Laboratory. A number 
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of crystals were screened to identify the one with strong anomalous scattering at the K-edge 
absorption of selenium. The distance of the detector to the crystals was set to 150 mm. The 
wavelength of 0.9795 Å was chosen for selenium SAD phasing. The crystals were exposed for 
10 or 15 seconds per image with one degree oscillation, and a total of 180 images were taken for 
each data set. All the data were processed using HKL2000 and DENZO/SCALEPACK.46 
 
Table 2.2.4. Data collection and refinement statistics of 2-Se-U-RNA 8mer 
The crystal structure study of the SeU-RNA [5’-rGUAUA-SeU-AC-3’] is consistent with 
the biophysical results of SeU/A pairing. Similar to the native, the Se-RNA crystal is also in 
rhombohedral space group R32. The Se-RNA structure, determined at 2.3 Å resolution, is 
virtually identical to the native one47 (at 2.2 resolution, Figure 2.2.7). Interestingly, the Se-RNA 
crystals grew much faster than the native ones. In six days, the Se-RNA formed diffraction-
quality crystals in decent sizes (approximately 0.05 x 0.05 mm), while the corresponding native 
identify the one with strong anomalous scattering at the
K-edge absorption of selenium. The distance of the
detector to the crystals was set to 150mm. The wavelength
of 0.9795 A˚ was chosen for selenium S D phasing. The
crystals were exposed for 10 or 15 s/image with 1! oscilla-
tion, and a total of 180 images were taken for each data
set. All the data were processed using HKL2000 and
DENZO/SCALEPACK (21).
Structure determination and refinement
The structure of the Se-RNA [50-GUAUA-SeU-AC-30]2
was solved by molecular replacem nt with both CN
(22) and Phaser (23). The refinement protocol includes
simulated an ealing, positional refinement, restrained
B-factor refinement, and bulk solvent correction.
The stereo-chemical topology and geometrical restrain
parameters of DNA/RNA (24) have been applied.
The topologies and parameters for modified uridine with
2-selenium (US) were constructed and applied.
After several cycles of refinement, a number of highly
ordered waters were added. Finally, the occupancies of
selenium were adjusted. Cross-validation (25) with a
5–10% test set was monitored during the refinement.
The sA-weighted maps (26) of the (2 mjFoj"DjFcj) and
the difference (mjFoj"DjFcj) density maps were
computed and used throughout the model building
(Table 3).
RESULTS AND DISCUSSION
Synthesis of 2-Se-uridine phosphoramidite
Though selenium was incorporated into uridine four
decades ago (27,28), RNA containing 2-Se-uridine (SeU)
has not been synthesized because of the synthetic chal-
lenge. Recently, our laboratory has successfully developed
a novel strategy to incorporate the selenium functionality
to the 2-position of thymidine in DNA (29). This success-
ful strategy has encouraged us to introduce the selenium
functionality to the 2-position of uridine in RNA. Herein,
we report the first synthesis of the 2-selenouridine deriva-
tives and RNAs. The synthesis (Scheme S1 in
Supplementary Data) started from the glycosidation (30)
of the acylated ribofuranose (1) with silylated 2-thiouracil
(3), followed by benzoyl deprotection and trityl protection
of the 50-hyroxyl group to offer 6 (31). After methylation
of 6 to activate the 2-thio-functionality (29), NaSeH was
used to displace the 2-S-functionality and offer the
2-Se-uridine 8 in 85% yield. Following the protections
of the 20-hydroxyl group and the 2-Se-functionality
with ICH2CH2CN, the Se-phosphoramidite 11
was synthesized by phosphitylation of 10 a (29,32,33).
The SeU-phosphoramidite was finally incorporated
into RNAs by solid-phase synthesis. The synthesized
SeU-RNAs (12) were deprotected, purified and con-
firmed by HPLC and MS (Table 1 and Figure 2).
The characterization of the Se-nucleosides and
Se-nucleotides is presented in Supplementary Figures
S1–S23.
Characterization of the 2-Se-functionalized RNA
After cleavage from solid support and deprotection, the
crude DMTr-on RNAs were purified by RP-HPLC and
lyophilized to dryness. As shown in Figure 2A, the
coupling yield is #90%. The 50-DMTr deprotection of
the oligonucleotides was then performed using Glen-Pek
RNA column. The HPLC analysis of the DMTr-off RNA
was shown in Figure 2B. All the pure seleno-RNA oligo-
nucleotides were characterized by MALDI-TOF
MS (Table 1).
Thermodenaturization study of 2-Se-uridine RNAs
containing match and mismatch base pairs
UV-melting temperatures (Tm) of the native and
Se-modified duplexes with match and mismatch sequences
are shown in Table 2, Figures 4 and 5. Tm of the Se-RNA
duplex containing the SeU/A Watson–Crick pair was
3.0!C higher for one duplex (or 2.4!C higher for the
other duplex) than those of the corresponding duplexes
containing native U/A pair (Table 2). Comparing with
native U/G, the SeU/G pair is #4!C less stable than the
native U/G pair, suggesting that SeU discourages the SeU/
G pair formation. While the SeU/C mis-pair is slightly less
stable than the native U/C mis-pair, the SeU/U mis-pair is
more stable than the native U/U mis-pair. The higher
stability may be attributed to the higher acidity of the
imino group (3-NH) of SeU [pKa=7.29±0.02,
Figure 3, compared to that of the native uridine
(pKa=9.18±0.02) (34)], which may promote U/U inter-
action via hydrogen bond. In addition, considering a
selenium atom is 0.43 A˚ larger in atomic radius than an
oxygen atom, the 2-Se atom may strengthen the stacking
interaction between SeU and its 30-nucleobase
(Supplementary Figure S24).When directly comparing
the Watson–Crick base pairs (U/A and SeU/A) with
their own corresponding mis-pairs, it is clear that SeU/A
pair has the balanced discrimination against all mis-pairs,
Table 3. Data collection and refinement statistics of SeU-RNA
Structure (PDB ID) GUAUA-SeU-AC (3S49)
Data collection
Space group R32
Cell dimensions: a, b, c (A˚),
a, b, g (!C)
47.095, 47.095, 424.655,
90, 90, 120
90, 90, 120
Resolution range (A˚) (last shell) 50.0–2.28 (2.37–2.28)
Unique reflections 9870 (959)
Completeness (%) 99.8 (99.4)
Rmerge (%) 7.7 (23.5)
I/s(I) 21.0 (3.9)
Redundancy 18.8 (10.7)
Refinement
Resolution range (A˚) 30.0–2.3
Rwork(%) 21.4
Rfree (%) 26.9
Number of reflections 8206
Number of atoms
Nucleic acid (double) 1162
Heavy atoms and ion 7 Se
Water 71
RMS deviations
Bond length (A˚) 0.007
Bond angle 1.169
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did not crystallize in 3–4 weeks under the same conditions. Moreover, the Se-RNA crystals 
could form in broader buffer conditions (12 out of 24 conditions in Hampton buffers) than the 
corresponding native (2 out of 24 conditions). This observation of faster crystal growth of the Se-
RNA is consistent with the Se-facilitated duplex stability. As shown in Figure 2.2.7A, there are 
seven self-complementary RNA molecules in a unit cell, and the overall shape of the duplexes is 
almost linear (approximately 8o inclination to the screw axes). Although this assembling pattern 
results in the discontinued backbones and grooves, the duplexes stack on top of each other in a 
head-to-tail fashion, and a peudo-fiber is formed. The data collection and structure refinement 
statistics are summarized in Table 2.2.4. 
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Figure 2.2.7. Global and local structures of the SeU-containing RNA r[5’-GUAUA(SeU)AC-3’]2 
with a resolution of 2.3 Å.  
(A) The overall structure of duplex. (B) The superimpose comparison of one SeU-RNA duplex 
(red; PDB ID: 3S49) with its native counterpart [5’-r(GUAUAUA)-dC-3’]2 (cyan; PDB ID: 
246D) with a RMSD value 0.55. The two red balls represent the selenium atoms. (C) The 
experimental electron density of SeU6/A11 base pair with s=1.0. (D) The superimpose 
comparison of the local base pair SeU6/A11 (red) and the native U6/A11 (cyan). The numbers 
indicate the distance between the corresponding atoms. 
  
Since 2-exo-oxygen of uridine is not involved in the hydrogen bond interactions of U/A 
pairing, it’s expected that the U/A pair will accommodate the larger selenium atom at this 
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position (Figure 2.1.1 and Figure 2.2.7C). The Se-modification also leads to the acidity increase 
of the 3-imino group (NH) in the 2-Se-uridine, which strengthens the hydrogen bond between N3 
of U6 and N1 of A11. Indeed, after the selenium modification, the U/A hydrogen bond length 
between N3 of U6 and N1 of A11 is shortened from the native distance (3 Å) to the Se-modified 
distance (2.81 Å). Moreover, after the Se-modification (Figure 2.2.7D), the U/A hydrogen bond 
length between O4 of U6 and N6 of A11 decreases by 0.47 Å from the native distance (3.39 Å) 
to the Se-modified distance (2.92 Å). The shortened H-bond lengths indicate stronger H-bonds, 
which may explain the increase of duplex stability after the Se-modification. On the contrary, the 
distance between Se2 of U6 and C2 of A11 in the Se-modified duplex is slightly increased. This 
distance increase is likely due to a steric effect. This steric clash at the position 2 of the Se-
uridine can be a driving force to increase SeU/A pair specificity. Consistent with our biophysical 
study, our structure study has indicated that the selenium bulkiness at the uridine 2-postion 
discourages the U/G wobble pairing. Moreover, due to the electronic effect of a selenium atom, 
the inability of a Se atom to form a stable hydrogen bond is another main factor responsible for 
the discrimination against U/G wobble pair. 
2.3 Study of U/G Wobble Pair 
2.3.1 U/G wobble pair experimental design and crystallization 
Base on our biophysical studies, we were able to confirm the modified 2-Se-uridine is 
able to maintain the U/A base pair stability meanwhile destabilizing U/G wobble pair. Our 2.3Å 
resolution crystal structure of SeU/A RNA base pair further prove that the selenium atom did not 
disrupt the overall structure of the RNA but slightly shorten the local hydrogen bonding of the 
SeU/A pair and enhance the stacking of the SeU/A pair with neighboring base pairs. To further 
explore the SeUG wobble pair in the real structure and for better comparison, we choose the 
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same self-complimentary sequence but switch the A to a G against SeU for the study. The newly 
designed sequence (5’-GUGUAUAC-3’) should form two UG wobble pairs in the eight bases 
double helix region (Figure 2.3.1). Both the native RNA sequence (5’-GUGUAUAC-3’) and Se-
modified RNA sequence (5’-GUGUASeUAC-3’) were synthesized through solid phase synthesis 
and purified by HPLC for crystal growth. The integrity of the Se-modified RNA is approved by 
mass spec analysis, Chemical Formula: C76H95N29O54P7Se, [M+H+]+: 2574.3, observed 2574.4 
(Figure 2.3.1). 
 
Figure 2.3.1. Design of RNA duplexes.  
Left: 5’-GUAUAUAC-3’ with all Watson-crick base pairs. Right: 5’-GUGUAUAC-3’ with two 
UG wobble pairs. Base pairs of interests were labeled in red. 
 
The purified RNAs was adjusted to 1 mM concentration and was annealed with itself by 
heating up to 80oC and then was slowly cool to room temperature. The 24 screening buffers were 
from Hampton Research Nucleic Acid Mini screen kit (APPENDICES). The RNA was mix with 
screening buffer at 1:1 ratio hanging against 35% MPD (2-methyl-2,4-pentanediol). Among 24 
conditions, the native sequence (5’-GUGUAUAC-3’) was crystallized in four conditions (No. 
10, 15, 17, 19) with in 24 hours while Se-modified sequence (5’-GUGUASeUAC-3’) was 
crystallized in thirteen conditions (No. 2, 3, 4, 6, 8, 10, 11, 12, 15, 17, 19, 20, 21) with in 24 
hours. The native crystals perform rod-shaped while the Se-modified crystals appear long 
needle-shaped (Figure 2.3.2). 
 
 
 
5'- G U G U A  U A  C -3'
3'- C A  U A  U G U G -5'
5'- G U A U A  U A  C -3'
3'- C A  U A  U A U G -5'
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Figure 2.3.2. Crystal growth comparison with native and Se-modified RNA in 24 hours.  
Left: Native RNA crystal (5’-GUGUAUAC-3’) with four buffer conditions. Right: Se-modified 
RNA (5’-GUGUASeUAC-3’) with thirteen buffer conditions. 
 
2.3.2 Crystal structure of Native 5’-GUGUAUAC-3’ RNA 
 
Figure 2.3.3. Global and local structures of native RNA 5’-GUGUAUAC-3’  
A. Global structures of native RNA 5’-GUGUAUAC-3’; B. Wobble pairs G3/U14 and U6/G11 
with strontium ion at C4 position of uridine. 
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The native 5’-GUGUAUAC-3’ structure was determined at 2.2 Å resolution with molecular 
replacement (PDB ID: 1JAB), the data was collected at beam line BL8.2.2 of the ALS 
(Advanced Light Source) at the Lawrence Berkeley National Laboratory. The structure of the A-
form RNA shows a perfect 8-base duplex with two UG wobble pairs buried in the middle. The 
structure was deposited in PDB (1JAB). From the structure, the two UG pairs (G3U14 and 
U6G11) were both stabilized by strontium ions at C-4 position carbonyl of uridine (Figure 
2.3.3). The UG wobble pairs were also compared with U/A Watson-crick base pairs by global 
structures superimpose of the both RNA sequences (Figure 2.3.4). The structures were almost 
identical and no significant perturbation observed. 
 
Figure 2.3.4. Native RNA 5’-GUGUAUAC-3’ and 5’-GUAUAUAC-3’ structures. 
A. Native RNA structure (5’-GUAUAUAC-3’) PDB: 246D with all watson-crick base pairs; B. 
Native RNA structure (5’-GUGUAUAC-3’) PDB: 1JAB with two wobble base pairs; C. 
Superimposed of 1JAB and 246D structures. 
 
 
A. B. C. 
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2.3.3 Crystal structure of 5’-GUGUASeUAC-3’ RNA 
 
Figure 2.3.5. Hydrogen bonding pattern of 2SeU/A base pair and 2SeUG wobble pair. 
 
The actual structure of the Se-modified was not as expect as the native structure (5’-
GUGUAUAC-3’). However, the selenium atom at C2 of uridine generates a great hindrance 
when pairing with G to form a wobble pair (Figure 2.3.5), thus RNA refuses to form an 8-based 
double-strand helix. Instead, each RNA duplex is formed with 6 base pairs and a two nucleotides 
overhang on each end (Figure 2.3.6). In this particular situation, the Se-modified uridine forms 
SeU/A watson-crick base pair to avoid the SeUG wobble pair but rather to form two native UG 
wobble pair at each of the overhang end with neighboring duplex, which made it altogether two 
UG wobble pairs and two SeU/A watson-crick base pairs in each 8-based unit. This observation 
has strongly confirmed our previous hypothesis again that when the uridines at wobble base pair 
positions are replaced by SeU, the UG wobble pair was strongly discouraged. 
 
Figure 2.3.6. The SeU-RNA (5’-GUGUASeUAC-3’) crystal structure formation. 
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The 5’-GUGUASeUAC-3’ structure was determined at 1.5 Å resolution with molecular 
replacement (PDB ID: 1JAH). The data was collected at beam line BL8.2.2 of the ALS 
(Advanced Light Source) at the Lawrence Berkeley National Laboratory. This high-resolution 
structure offers the most detailed 2SeU containing RNA structure to date. In each duplex pair, 
there are two selenium atoms in the minor groove of A-form RNA, with distance of 3.69 Å, 3.93 
Å, and 3.93 Å respectively (Figure 2.3.7). The structure indicated a three RNA duplex bundle in 
the asymmetric unit. The intermolecular contacts of the overhand UG interactions between 
duplexes probably drive the packing of crystals.  
 
Figure 2.3.7. Structure of 5’-GUGUA2SeUAC-3’ RNA with electron density map. 
A. Three duplexes bundle in asymmetric unit; B. RNA duplex with two nucleotides overhang on 
each end; C. 2SeU/A and U/A base pairs superimposed with each other and the measurements of 
the hydrogen bonds. 
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3     2-SELENOURIDINE TRIPHOSPHATE SYNTHESIS AND SE-RNA 
TRANSCRIPTION 
3.1 Introduction 
The text of this work has been published as “2-Selenouridine Triphosphate Synthesis and 
Se-RNA Transcription”, RNA, 2013, 19, 1309-1314. I would like to acknowledge Dr. Sibo 
Jiang, Dr. Julianne Caton-Williams, Dr. Hehua Liu and Dr. Zhen Huang for their intellectual 
contribution as co-authors. 
3.1.1 RNA modification 
RNA is involved in numerous biological processes, such as genetic storage, transcription, 
translation, and regulation.2a, 27b Moreover, RNA can fold into well-defined three-dimensional 
structures to interact with proteins and catalyze biochemical reactions.1b, 2b The appreciation for 
the uniqueness of RNAs, especially non- coding RNAs for their structure and function 
diversities, has increased extensively in the past decade. However, the functional understanding 
of these complicated macromolecules is often limited. The functional understanding of many 
natural modifications of the RNAs is even less. Thus, studying RNA natural modifications has 
become a very active research area in order to better understand biophysical and chemical 
properties of RNAs (such as tRNA and rRNA). So far, >100 RNA modifications have been 
discovered in nature,5 and many of them are frequently dis- covered in tRNA. 2-Selenouridine (2-
SeU or SeU) is one of naturally occurring nucleosides and exists at the wobble position of the 
anticodon loop in various bacterial tRNAs (Escherichia coli, Methanococcus vannielii, 
Clostridium sticklandii, etc.).5, 18 This Se-modification might play a critical role in the mRNA 
decoding process. It was hypothesized that the 2-Se-modification may enhance the accuracy and 
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efficiency of protein translation.9a, 48 
3.1.2  Selenium in X-ray crystallography 
Moreover, another advantage of selenium modification in nucleic acid research is its 
assistance in addressing phase issue in X-ray crystallography via multiwavelength anomalous 
dispersion (MAD) or single-wavelength anomalous dispersion (SAD). Heavy atoms, such as 
selenium (Se) and bromine (Br), are suitable as anomalous scattering centers, which have been 
extensively applied in protein and nucleic acid crystallography. Encouraged by the successful 
selenium-assisted MAD phasing,49 we have pioneered and established nucleic acid X-ray 
crystallography with selenium derivatization.9b, 11, 50 Among the synthesized Se-derivatives, 2-
selenouridine is stable and the only one found in nature so far. Furthermore, the single oxygen 
atom substitution with selenium at the exo-2 position doesn’t interfere with the hydrogen 
bonding in the Watson-Crick U/A base pair, thereby preserving the base-pairing function and 
structure.9a Therefore, the 2-selenouridine synthesis and its incorporation into RNAs may largely 
facilitate both structure and function investigations. 
3.1.3 Methods for Se-RNA synthesis 
Generally, there are two strategies to synthesize the Se-derivatized RNAs: solid-phase 
synthesis, and transcription. The first method offers the site-specific incorporation of the Se-
nucleoside. However, it is limited to relatively short RNAs (up to 50 nt) for large-scale synthesis. 
In addition, it requires multiple steps in deprotection and purification. The 2-selenouridine 
chemical incorporation into RNAs has been achieved via solid-phase synthesis.9a Our biophysical 
studies have shown that the 2-Se-modification discriminates against a U/G mismatch (wobble 
pair), while pre- serving the native U/A pair. This result indicates that SeU can largely improve 
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the RNA base-pairing specificity and the RNA–RNA interaction fidelity. This result has 
encouraged us to incorporate the Se-modification into RNA by in vitro transcription, in order to 
further investigate the function and structure of the SeU-RNAs, such as the SeU-containing 
tRNAs. This enzymatic method can allow synthesis of longer RNAs (>50 nt) in a large quantity 
(multiple milligrams). Multiple selenium atoms can also be conveniently incorporated into RNA 
under the mild conditions. As a matter of fact, the transcription strategy with T7 RNA 
polymerase is favored by most molecular and structural biologists. Herein, we report the first 
synthesis of 2-selenouridine triphosphate (SeUTP) and the enzymatic incorporation of SeUTP into 
noncoding RNAs. The active and mutant hammerhead ribozymes (Figure 3.1.1) were 
successfully transcribed and examined with SeUTP. The transcribed SeU-hammerhead ribozyme 
is active, suggesting that the SeU- RNAs are useful in both function and structure studies of 
noncoding RNAs. 
 
Figure 3.1.1. Hammerhead ribozymes.  
(A) Secondary structure of the self-cleaving SeU-hammerhead ribozymes, including the wild type 
(WHR) and crippled mutant (MHR). The mutant and cleavage sites are indicated by arrows. 
Highly conserved bases are highlighted in gray. (B) Secondary structure of the non-self- cleaving 
SeU-hammerhead ribozyme and its 5’-32P-labeled RNA substrate. 
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3.2 General Experiment Section 
3.2.1 2-Se-uridine triphosphate synthesis 
In order to minimize by-product formation, the Se-nucleobase modifications are normally 
protected during chemical synthesis.9a, 20-21, 51 Since the 2-seleno-modification on uridine is 
naturally occurring, we decided to directly explore its compatibility with chemical synthesis. We 
were pleasantly surprised that 2-seleno-uridine, without protection, can be directly converted to 
the corresponding triphosphate. Thus, the synthesis (Scheme 3.2.1) of SeUTP (3) started from 
deprotection of the 5’-DMTr group of the Se-uridine derivative 19a under an acidic condition. 
Then, 2-Se-uridine (2) was converted to SeUTP (3) via a one-pot synthesis: sequential treatments 
with phosphorus oxychloride (POCl3), pyrophosphate, and bicarbonate.51a, 52 
 
 
Scheme 3.2.1. Chemical synthesis of SeUTP and transcription of SeU-containing RNA. 
Reagents and conditions: (a) 4% trifluoroacetic acid; (b) POCl3, Me3PO4; (tri-n-butyl)amine, 
pyrophosphate, N, N-dimethyl-formamide; the H2O hydrolysis; (c) RNA transcription. 
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3.2.1.1 Synthesis of 2-Se-uridine 
Trifluoroacetic acid (11 mg) was added to 5’-DMTr-2-Se-uridine (Scheme 3.2.1, step 1, 
305 mg, 0.5 mmol)9a (Sun et al. 2012) in dichloromethane (5 mL). The solution was heated at 
40°C for 30 min, followed by adding methanol (0.2 mL). The reaction was stirred vigorously for 
another 1 h to obtain a light yellow precipitate product (Scheme 3.2.1, step 2). The precipitate 
was recovered by centrifugation or filtration; the yield of step 2 was almost quantitative. 
3.2.1.2 Synthesis of 2-Se-uridine triphosphate 
2-Se-uridine (Scheme 3.2.1, step 2, 20 mg) was weighed and dried in a flask under high 
vacuum overnight, followed by injecting trimethyl phosphate (0.4 mL) to dissolve it and then 
stirring the flask in an ice bath. A solution of proton-sponge (55 mg, 2 eq) in trimethyl phosphate 
(0.3 mL) was injected into the solution of step 2 at 0°C. After 3 min stirring, phosphorus 
oxychloride (POCl3; 9 μL, 1.5 eq) diluted in trimethyl phosphate (90 μL) was dropwise added 
into the solution of step 2 at 0°C. The reaction was completed in 1.5 h (monitored on TLC). 
Tributylammonium pyrophosphate (64 mg, 2 eq., dissolved in 0.2 mL tributylamine and 0.4 mL 
DMF) was then quickly injected into the reaction. After vigorously stirring for 5 min, the 
reaction was quenched with triethylammonium bicarbonate (1 M, 3 mL) and stirred for another 1 
h at the room temperature to obtain compound 3. To the reaction solution, NaCl (3 M NaCl, 0.5 
mL) was added, followed by adding ethanol (14.5 mL) and freezing the suspension at −80°C for 
1 h to precipitate the crude product. Compound 3 was recovered by centrifugation for 25 min at 
14,000 rpm. The pellet was redissolved in water and analyzed by HPLC. SeUTP (step 3) was 
purified by HPLC. The identity of SeUTP as a triethylammonium salt was confirmed by NMR 
(1H-, 13C-, and 31P-NMR) and mass analyses. 1H-NMR (400 MHz; D2O) δ: 8.22 (d, J = 8.1 Hz, 
1H, H-6), 6.79 (d, J = 3.0 Hz, 1H, H-1’), 6.38 (d, J = 8.1 Hz, 1H, H-5), 4.54–4.33 (m, 5H, H-2’, 
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3’, 4’, 5’), 3.21 (d, J = 7.3 Hz, CH2 of triethylammonium), 1.28 (t, J = 7.3 Hz, CH3 of 
triethylammonium). 13C-NMR (100 MHz; D2O) δ: 174.7 (s, C-4), 161.7 (s, C-2), 140.9 (s, C-6), 
107.6 (s, C-5), 94.6 (s, C-1’), 82.2 (d, J = 9.1 Hz, C-4’), 74.0 (s, C-2’), 67.3 (s, C-3’), 62.9 (d, J = 
5.1 Hz, C-5’), 45.6 (s, CH2 of triethylammonium), 7.2 (s, CH3 of triethylammonium). 31P-NMR 
(162 MHz; D2O) δ: −7.4 (d, J = 19.7 Hz, α-P), −11.3 (d, J = 19.6 Hz, γ-P), −22.1 (t, J = 19.6 Hz, 
β-P). HRMS (ESI-TOF) [M-H+]- = 546.8812 (calc. 546.8829) 
3.2.1.3 Purification and analysis of 2-Se-uridine triphosphate 
The maximal UV absorbance of native uridine triphosphate is 260 nm, while that of the 
SeU-triphosphate is 307 nm. In the HPLC analysis, both the native and selenium-modified UTPs 
were monitored under two wavelengths (260 and 307 nm). The synthesized SeUTP was purified 
by HPLC (Ultimate XB-C18, 250 mm×21.2 mm, 10 μm) with a gradient of 100% buffer A (20 
mM triethylammonium acetate in water) to 25% buffer B (20 mM triethylammonium acetate in 
50% acetonitrile and 50% water) for 20 min. The HPLC analysis was performed (Ultimate XB-
C18, 250 mm × 4.6 mm, 5 μm) with a gradient from 100% buffer A (20 mM triethylammonium 
acetate in water) to 40% buffer B (20 mM triethylammonium acetate in 50% acetonitrile and 
50% water) for 15 min. The HPLC and UV profiles are shown in Figure 3.2.1. The retention 
times of the native UTP and SeUTP were 11.2 and 14.1 min, respectively. 
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Figure 3.2.1. HPLC and UV analyses of SeUTP.  
A) HPLC profiles: a) Native UTP monitored at 260 nm (retention time: 11.2 min); b) Native 
UTP monitored at 307 nm; c) SeUTP monitored at 260 nm (retention time: 14.1 min); d) SeUTP 
monitored at 307 nm (retention time: 14.1 min); e) co-injection of both native UTP and SeUTP 
monitored at 260 nm (retention time: 11.2 min and 14.1 min); f) co-injection of both native UTP 
and SeUTP monitored at 307 nm (retention time: 14.1 min). B) UV-spectrum of SeUTP (lmax= 307 
nm).   
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3.2.2 Transcription of RNAs 
Transcription experiment was carried out following standard procedures from 
manufacturer Epicentre (AmpliScribe™ T7-Flash™ Transcription Kit). ATP [α-32P] was use as 
radioactive labeling material in this experiment. For each reaction (5 μL), final concentration of 
0.5 mM NTP (A, U, G, C in the transcription of native RNAs and A, SeU, G, C in the 
transcription of Se-modified RNAs), 50 ng/μL linearized DNA plasmid template, 10 mM DTT, 
1×transcription buffer for T7 RNA polymerase and 0.5 μL of T7 RNA polymerase (10 U) were 
added into reaction tube with RNase-free water to adjust total reaction volume to 5 μL. In 
transcription efficiency (time-course) experiment, a gel loading dye (5 μL) with 100 mM EDTA 
was used to terminate reaction at each time point with additional heating (75oC for 30 min). Later 
the experimental result was visualized via denaturing urea PAGE gel (15%) and 
autoradiography. Two templates practiced in transcription experiments were double-stranded 
DNA prepared by PCR. The translated RNAs are mutant hammerhead ribozyme (MHHR) with 
sequence of 5’-
GGGAGCCCUGUCACCGGAUGUGCUUUCCGGUCUGAUGAGUCCGUGAGGACAAAAC
AGGGCUCCCGAAUU-3’ (Figure 3.1.1) and wild-type hammerhead ribozyme (WHHR) with 
sequence of 5’-
GGGAGCCCUGUCACCGGAUGUGCUUUCCGGUCUGAUGAGUCCGUGAGGACGAAAC
AGGGCUCCCGAAUU-3’ (Figure 3.1.1).53 
 
3.2.2.1 Transcription with native NTPs 
All native NTPs, the transcription buffer, and T7 RNA polymerase used in 
our transcription experiments were purchased from Epicentre. The templates of the 
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wild-type and mutant hammerhead ribozymes were from the linearized plasmids 
(Lin et al. 2011a). The native RNAs were transcribed with the transcription protocol (final 
concentration) in RNA polymerase buffer (40 mM Tris-HCl, 6 mM MgCl2, 2 mM spermidine, 
pH 7.9), DTT (10 mM), ATP, UTP, CTP, and GTP (0.5 mM each NTP), DNA template (non- 
self-cleaving hammerhead ribozyme: 1 μM dsDNA template [55 nt]; self-cleaving hammerhead 
ribozyme [mutant and wild-type]: 50 ng/μL linearized plasmid), T7 RNA polymerase (2 
units/μL, Epicentre), and RNase-free water to adjust to the final volume (e.g., 20 μL). The 
transcription reaction was incubated for 1 h at 37°C. 
3.2.2.2 Transcription and analysis of Se-RNAs 
The Se-RNAs were transcribed with the transcription protocol (final concentration) in 
RNA polymerase buffer (40 mM Tris-HCl, 12 mM MgCl2, 2 mM spermidine, pH 7.5), DTT (10 
mM), ATP, SeUTP, CTP, and GTP (0.5 mM each NTP), DNA template [non-self-cleaving 
hammerhead ribozyme: 1 μM dsDNA template (55 nt); self-cleaving hammerhead ribozyme 
(mutant and wild-type): 50 ng/μL linearized plasmid], T7 RNA polymerase (4 units/μL, 
Epicentre), and RNase-free water to adjust to final volume (e.g., 20 μL). The transcription 
reaction was incubated for 3 h at 37°C. To examine the SeUTP compatibility with RNA 
polymerase in transcription, the linearized plasmid templates for the wild-type hammerhead-
ribozyme (WHR) and the crippled mutant hammerhead-ribozyme (MHR) were used (Figure 
3.1.1) for the SeU-RNA transcription. As expected, SeUTP was recognized by T7 RNA 
polymerase (Figure 3.2.2A). Moreover, the mutant SeU-ribozyme (69-nt; containing 15 selenium 
atoms) was pre- pared via RNA transcription, and the integrity of the SeU-ribozyme (SeU-MHR) 
was confirmed by MS analysis (Figure 3.2.2C). 
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Figure 3.2.2. The SeU-ribozymetranscription with SeUTP and T7 RNA polymerase.  
(A) The auto-radiography gel image of in vitro transcription; (left) transcription of the native 
RNA (the crippled mutant hammerhead-ribozyme: MHR) with all native NTPs; the minor faster-
moving band is the self-cleaved product (fragment); (right) transcription of the SeU-MHR with 
SeUTP and other native NTPs. (B) Optimized Se-RNA transcription (∼85% yield compared to 
the corresponding native RNA transcription). Transcription conditions are listed in Table 3.2.1. 
C) MALDI-TOF MS analysis of the SeU-MHR (molecular formula: C657H817N264O476P71Se15); 
matrix: 3-hydroxypicolinic acid (3HPA, molecular formula: C6H5NO3); mass of SeU-MHR and 
matrix observed: 23550.9 (calc. 23551.4). 
 
 
3.2.2.3 Optimization of SeU-RNA transcription 
To maximize the transcription yield, condition optimizations have been performed. The 
linearized plasmid of the mutant hammerhead ribozyme (Figure 3.1.1) was used as the template, 
which incorporates 15 SeUs into the ribozyme. The transcription buffers with various pH values 
were first examined, since the acidity of the imino group (3-NH) of SeU is higher than that of the 
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native U.9a The pH values of the transcription buffer (40 mM Tris base or sodium phosphate, 6 
mM MgCl2, 2 mM spermidine, and 10 mM DTT) were adjusted. The Se-RNA transcription was 
examined under eight pH values (pH 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, and 9.0) and indicated that 
pH 7.5 was optimal for the Se-RNA transcription (Figure 3.2.3). The pH of the standard 
transcription buffer is 7.9.  
 
Figure 3.2.3. Experimental results of transcription optimizations with SeUTP.  
(A) Optimization of the transcription buffer pH (5.5–9.0). pH 7.5 is optimal for the Se-RNA 
transcription, while the pH of the standard transcription buffer is 7.9. (B) Data analysis of the pH 
optimization. 
 
Mg2+ concentration in the transcription buffer was also examined by varying it from 4 to 
12 mM. As the increased MgCl2 concentration yielded higher transcription yield (Figure 3.2.4A), 
12 mM MgCl2 was chosen for the Se-RNA transcription. Other components, such as spermidine 
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(from 2–8 mM) and SeUTP (from 0.5 to 1.5 mM), were also examined for the transcription 
optimization. However, we found that increases of the concentrations of these components 
slightly decreased the transcription yield (Figure 3.2.4B). 
Table 3.2.1. Optimized conditions for the Se-RNA transcription 
 pH Mg2+ UTP concentration 
T7 
polymerase 
Transcription 
time 
Native 
condition 7.9 6 mM 0.5 mM 10 units 1h 
Se-modified 
condition 7.5 12 mM 0.5 mM 20 units 3h 
 
 Moreover, a higher quantity of T7 RNA polymerase can increase the Se-RNA 
transcription yield (Figure 3.2.4C). Finally, after combining these optimized conditions (Table 
3.2.1), we could increase the yield of the SeU-RNA transcription up to 85% of the corresponding 
native RNA (Figure 3.2.2B), and these conditions have been used to transcribe various SeU-RNA. 
Figure 3.2.4. Experimental results of transcription optimizations with SeUTP.  
A). Optimization with increasing MgCl2 concentrations. Standard transcription buffer contains 6 
mM MgCl2. B). Optimization with increasing spermidine concentrations. Standard transcription 
buffer contains 2 mM spermidine. C). Optimization with T7 RNA polymerase quantity (10 to 40 
unit/μL). 
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3.2.3 Catalytic activity analysis of the Se-RNAs 
3.2.3.1 Self-cleaving wild-type hammerhead ribozyme 
To examine hammerhead ribozyme activity with regard of time, we use the wild-type 
template to transcript both native and Se-modified ribozyme in a self-cleavage manner since the 
wild-type template directs active ribozyme synthesis while the ribozyme cleaves itself 
spontaneously (Figure 3.2.5A). The transcription reaction was carried out in standard T7 reaction 
buffer (containing 6 mM MgCl2) and the result clearly indicated that under standard transcription 
condition the native hammerhead ribozyme cleavage itself completely while Se-modified 
ribozyme is quite active but the cleavage is not complete. Later, we examined the selenium 
modified ribozyme activity in a transcription solution with increased MgCl2 concentration to 10 
mM (ref). Under this condition, Se-modified ribozyme gives a complete and efficient activity 
(Figure 3.2.5B). 
 
 
Figure 3.2.5. Wild-type native and Se-modified ribozyme transcription with self-cleavage 
activity during synthesis.  
A) The experiment is carried out under standard transcription buffer condition (40 mM Tris-HCl, 
6 mM MgCl2, 10 mM NaCl, 2 mM spermidine and 10 mM DTT) and a mutant native and Se-
modified ribozyme was used as comparison respectively. B) Wild-type selenium modified 
ribozyme transcription with a standard transcription buffer of 10 mM MgCl2. A Se-modified 
mutant ribozyme is used as comparison. 
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3.2.3.2 Non-self-cleaving hammerhead ribozyme 
The non-self-cleaving hammerhead ribozyme (5’-GGCA-ACCUGA 
UGAGGCCGAAAGGCCGAAACGUACA-3’) (Figure 3.1.1) for the catalytic experiments was 
transcribed following the standard procedures described above. The DNA template used for this 
transcription was a 55-nt dsDNA (5’-
TGTACGTTTCGGCCTTTCGGCCTCATCAGGTTGCCTATAGTGAGTCGTATTACGC-3’ 
and its complementary sequence). After the transcription, the native and Se-modified ribozymes 
were purified and adjusted to the same concentration (monitored by UV). The RNA substrate (20 
nt, 5’-ACCUGUACGUCGUUGCCUAA-3’) (Figure 3.1.1) chemically synthesized by solid-
phase synthesis was kinased with γ-32P-ATP at the 5’ end for the ribozyme digestion. The 
digestion was performed in the buffer (10 mM Tris-HCl, 10 mM MgCl2, pH 7.6) and with 5’-32P-
labeled RNA substrate (final concentration: 50 μM) at 27° C. Aliquots (10 μL each) were taken 
at the time intervals (0, 5, 10, 30, 90, and 150 min), and each was mixed with EDTA (5 μL, 50 
mM) dissolved in a saturated urea solution (aqueous) to quench the digestion. The 5’-labeled 
RNA substrate was digested to the 9-nt fragment and the 5’-32P-RNA fragment (11 nt). The 32P-
labeled RNA allowed monitoring the substrate digestion via gel electrophoresis and 
autoradiography. The time-course results of the ribozyme digestion are shown in Figure 3.2.6. 
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Figure 3.2.6. The catalytic activity of the Se-modified ribozyme.  
(A) The time-course experiment of the 5’-32P-RNA substrate digested with the non-self-cleaving 
native and Se-modified hammerhead ribozymes under the same conditions. The experiment was 
carried out at room temperature, with 10 mM Mg2+, in the ribozyme buffer. (B) Time-course 
experiment of (A) with different 5’-32P-RNA substrate concentration. (C) Plot of the SeU-
ribozyme catalysis (dashed line) compared with the corresponding native (solid line). The 
cleavages of the RNA substrate by the native and Se-modified ribozymes (y-axis) were 
normalized via comparison to the substrate cleavage by the native ribozyme at 150 min (defined 
as 1.0). 
 
54 
 
3.2.4 Thermostability of the SeU-RNA 
To examine the thermostability of the SeU-RNA, we designed a short Se-RNA (trimer: 5’-
USeUU-3’) for this study. This Se-RNA was chemically synthesized by solid-phase synthesis and 
purified.9a We heated the Se-RNA continually at 70°C for a few hours and monitored it by HPLC 
at both 260 and 307 nm, since the 2-selenium modification has a unique UV-absorption at 307 
nm, while the native nucleotides absorb strongly at 260 nm. The HPLC analysis was performed 
(Ultimate XB-C18, 250 mm × 4.6 mm, 5 μm) with a gradient from 100% buffer A (20 mM 
triethylammonium acetate in water) to 40% buffer B (20 mM trie- thylammonium acetate in 50% 
acetonitrile and 50% water) for 15 min. No significant decomposition was observed over 4-h 
heating at 70°C (Figure 3.2.7), indicating that this Se-modification is relatively stable. 
 
Figure 3.2.7. Thermostability study of SeU-RNA.  
5’-USeUU-3’ was heated at 70°C for several hours. HPLC was monitored at both 260 and 307 nm 
(retention time: 10.9 min). 
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4     SYNTHESIS AND TRANSCRIPTION OF COLORED 4-SELENOURIDINE 
TRIPHOSPHATE WITH A SINGLE ATOM SUBSTITUTION 
4.1 Introduction 
4.1.1 Se-modified RNA in nature 
RNA is essential biological molecule that performs critical functions in genetic 
information storage, transcription, protein synthesis and regulation. 2a, 27b The uniqueness of RNA 
is greatly appreciated by the scientific society for its diversified structures and functions and its 
extensive applications in nucleic acids-protein studies as well as therapeutic discoveries. 1b, 2b 
Although RNA research areas are very activate worldwide, the comprehensive structure and 
function of this biomolecule are not fully understood due to its complexity and often times due to 
current technique limitations. Therefore, enormous artificial RNA modifications have been 
developed to improve their chemical properties, to diversify their functionality and to increase 
their stability and fidelity. There are over one hundred naturally occurring RNA modifications 
have been discovered to date.5 Most of the modifications exist in tRNA including a selenium-
modified nucleobase - 2-selenouridine. This selenium-modified uridine occurs at the wobble 
position of the anticodon loop in several bacterial tRNAs (Escherichia coli, Clostridium 
sticklandii, Methanococcus vannielii, etc.),5, 18 and its functionality has been fully characterized 
recently by Sun et al. via chemical synthesis.9a   The experimental date has demonstrated that the 
Se-modification enhanced base pair fidelity by stabilizing the U/A base pair meanwhile 
discouraging the U/G mismatch without causing significant perturbation to the RNA structure. 
Moreover, the 2-Se-uridine triphosphate is recognizable by polymerase and Se-ribozyme is 
active. 
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4.1.2 4-Selenouridine 
 
Figure 4.1.1. The UV spectrum of native UTP and 4SeUTP.  
Native (red, λmax = 260 nm) and colored 4SeUTP (black. λmax = 365 nm). Inset: left: UTP 
(colorless); right: 4SeUTP (yellow). 
 
Our research lab has previously replaced the oxygen atom at position 4 of thymidine with 
selenium.51a 4-selenium uridine nucleoside has been synthesized over decades ago; however, it 
has been incorporated into RNA oligonucleotide only last year through solid phase synthesis.22 
The enzymatic recognition of 4-seleno-uridne is unknown due to synthetic challenges of 
triphosphates. Compare with 2-selenouridine, the 4-selenouridine and possesses a unique yellow 
color with a UV absorption of 365 nm (Figure 4.1.1). This property is extremely useful for RNA 
visualization, detection, as well as spectroscopic study and crystallography of RNAs and protein-
RNA complexes and interactions. Compare to other bulky molecules for RNA visualization, our 
new method only replace a single atom of the nucleobase to achieve such advancement. In 
addition, heavy atom such as selenium is a suitable anomalous scattering center for multi-
wavelength anomalous dispersion (MAD) or single-wavelength anomalous dispersion (SAD) in 
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protein and nucleic acid crystallography. Thus, this C=Se functionality provides another 
advantage of seleno-modified nucleic acid research in X-ray crystallography. 
4.1.3 SeU-RNA synthesis 
 
Figure 4.1.2. Hammerhead ribozyme.  
A) Secondary structure of the non self-cleaving (mutant) SeU-hammerhead ribozymes, including 
the wild-type (WHR) and crippled mutant (MHR). The mutant site and cleavage site are 
indicated by arrows. Highly conserved bases are highlighted in grey. B) Secondary structure of 
active SeU-hammerhead ribozyme with 5’-32P-labled RNA substrate. 
 
The two strategies to synthesize the Se-modified RNAs include solid-phase synthesis and 
transcription. The solid-phase synthesis method utilizes site-specific incorporation of the Se-
nucleoside phosphoramidite. This method is applied to large-scale synthesis but limited to 
relatively short RNAs (up to 50 nt.) due to technical issues. In addition, it requires multiple steps 
in deprotection and purification. The chemical incorporation of 4-selenouridine into RNAs has 
been achieved only last year.22 The enzymatic method on the other hand can allow synthesis of 
longer RNAs (>50 nt.) in a large quantity (multiple milligrams). In addition, this method can 
easily achieve multiple selenium atoms incorporation into RNA under the mild conditions.  In 
order to incorporate the 4-Se-uridine into RNA to further investigate the function and structure of 
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the SeU-RNAs by in vitro transcription, 4-selenouridine triphosphate need to be synthesized first. 
Herein we report the first synthesis of 4-selenouridine triphosphate (SeUTP) and the enzymatic 
incorporation of SeUTP into non-coding RNAs. Both active and mutant hammerhead ribozymes 
(Figure 4.1.2) were successfully transcribed and examined with SeUTP. The transcribed SeU-
hammerhead ribozyme is active, suggesting that the SeU-RNAs are useful in both function and 
structure studies of non-coding RNAs. 
 
4.2 General Experiment Section 
4.2.1 4-Selenouridine triphosphate synthesis 
 
Although the synthesis of 4-Se-uridine nucleoside has been achieved many years ago,54 it 
was only recently incorporated into RNA oligonucleotide by our laboratory22 through 4-Se-
uridine phosphoramidite synthesis. This solid-phase synthetic method is able to incorporate 
modified nucleobase into specific site of RNA with up to 50 nucleotides long. To obtain a longer 
modified RNA with an efficient and mild approach, herein we report the first synthesis of 4-
selenouridine triphosphate and its incorporation into longer RNA via in vitro transcription. To 
minimize the by-product formation, we protect the selenium atom during the chemical synthesis 
with cyanoethyl group.9a, 20-22, 51 Thus the synthesis (Scheme 4.2.1) of 4SeUTP (5) started with the 
activation of the commercial available uridine-nucleoside 1 with 2,4,6-
triisopropylbenzenesulfonyl chloride (TIBS-Cl) and 4-dimethylaminopyridine (DMAP) in 
tetrahydrofuran (THF) at position 4. Then, without purification, a sodium selenide solution 
(NCCH2CH2SeNa) generated by di(2-cyanoethyl) diselenide [(NCCH2CH2Se)2] and NaBH4 in 
ethanol was slowly injected into reaction to obtain compound 2.20 Compound 2 was deprotected 
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by triethylamine trihydrofluoride in THF at 40oC to obtain nucleoside 3. Compound 3 was 
treated with 4% trifluoroacetic acid in dichloromethane to achieve nucleoside 4. Via a one-pot 
synthesis, compound 4 was converted to protected 4-selenouridine triphosphate (4SeCH2CH2CNUTP, 
compound 5) by treating with phosphorus oxychloride (POCl3), pyrophosphate, and bicarbonate 
sequentially.19, 51a, 52 
 
Scheme 4.2.1. Chemical synthesis of 4SeUTP (5) and transcription of 4SeU-containing RNA. 
a) TIBSCl, DMAP, THF; b) (NCCH2CH2Se)2, NaBH4, EtOH; c) Triethylamine trihydrofluoride, 
THF, 40oC; d) 4% trifluoroacetic acid, CH2Cl2; e) POCl3, Me3PO4; (tri-n-butyl)amine, 
pyrophosphate, N, N-dimethylformamide; the H2O hydrolysis; f) K2CO3 (0.05 M) in methanol; 
g) RNA transcription. 
 
4.2.1.1 Synthesis of 4-selenouridine 
The starting material 1 (0.2 g, 0.37 mmol) and catalytic amount of 4,4’-
dimethylaminopyridine (DMAP, 3 mg) was dissolved in anhydrous THF under argon, followed 
by adding diisopropylethylamine (DIPEA, 1.85 mmol) and the reaction was stirred at room 
temperature. Then a solution of 2,4,6-trisopropylbenzenessulfonyl chloride (TIPCl, 0.56 mmol) 
pre-dissolved in THF was added into reaction dropwisely. The reaction was stirred for 1 hour 
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and monitored by TLC plate (5% methanol in dichloromethane). Without further purification, the 
reaction mixture was slowly added into a clear solution of sodium selenide (NCCH2CH2SeNa) 
pre-generated by adding ethanol (EtOH) into sodium borohydride (NaBH4, 2.2 mmol) and di(2-
cyanoethyl) diselenide [(NCCH2CH2Se)2, 1.83 mmol]. The reaction was stirred for another 1 
hour and monitored by TLC plate (5% methanol in dichloromethane, Rf = 0.6). After the 
reaction was complete, the crude compound 2 was dissolved in ethyl acetate and wash with 
saturated sodium chloride solution. The organic layer was then separated, dried over magnesium 
sulfate and evaporated into dryness. The compound was purified by flash column 
chromatography to obtain a pure slight yellow foam compound.55 Then the pure compound 2 (0.1 
g, 0.15 mmol) was dissolved in anhydrous THF and triethylamine trihydrofluoride (0.3 mmol) 
was added into reaction at 40oC. The reaction was stirred for 2 hours and monitored by TLC 
plate (7% methanol in dichloromethane). Once the reaction was complete, the crude reaction 
mixture was dried under reduced pressure and re-dissolved in dichloromethane. Later, 4% 
trifluoroacetic acid was added drop-wisely into the reaction until the pH reach 4.  After the 
reaction was complete, methanol (0.2 mL) was injected into the mixture and the organic layer 
was washed by water twice, then isolated, dried over magnesium sulfate and evaporated under 
reduced pressure. The crude compound 4 was purified by flash column chromatography and 
characterized NMR (1H- and 13C-NMR) and ESI-TOF analyses. Compound 4: 1H NMR (400 
MHz, CDCl3) δ: 8.09 (d, J = 7.0 Hz, 1H, H-6), 7.42 – 7.17 (m, 10H, aromatic and N-H), 6.83 (m, 
4H, aromatic), 6.09 (d, J = 7.0 Hz, 1H, H-5), 5.83 (d, J = 2.2 Hz, 1H, H-1′), 5.71 – 5.51 (br, 1H, 
2’-OH), 4.53 – 4.25 (m, 3H, H-3′, H-4′, 3′-OH), 3.80 (s, 6H, OMe), 3.58 – 3.41 (m, 3H, H-5′, H-
2′), 3.37 (t, J = 6.7 Hz, 2H, CH2-CN), 2.97 (t, J = 6.6 Hz, 2H, CH2-Se). 13C NMR (101 MHz, 
CDCl3) δ: 174.71 (C-4), 153.73 (C-2), 139.23 (C-6) 157.70,143.20, 139.23, 134.30, 134.10, 
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129.08, 127.09, 127.03, 126.17, 112.33 (Ar), 117.84 (CN), 105.79 (C-5), 91.95 (C-1′), 86.04 (C-
Ar), 84.10 (C-4′), 75.33 (C-2′), 69.62 (C-3′), 61.11 (C-5’), 54.30 (OCH3), 19.61 (CH2CH2CN), 
17.91(CH2-CN). Compound 3: 1H NMR (400 MHz, MeOD) δ: 8.32 (d, J = 7.0 Hz, 1H, H-5), 
6.56 (d, J = 7.0 Hz, 1H, H-6), 5.80 (s, 1H, H-1′), 4.14 (m, 3H, H-2′, H-3′, H-4′), 3.98 (dd, 1H, 
H5′), 3.79 (dd, 1H, H5′′), 3.38 (m, 2H, CH2-CN), 3.03 (m, 2H, CH2-Se). 13C NMR (101 MHz, 
MeOD) δ: 175.15 (C-4), 153.57 (C-2), 139.94 (C-6), 117.85 (CN), 105.83 (C-5), 91.03 (C-1′), 
83.54 (C-4′), 74.16 (C-2′), 67.39 (C-3′), 58.83 (C-5′), 19.19 (CH2CH2CN), 17.36 (CH2-CN). 
 
4.2.1.2 Synthesis of 4-selenouridine triphosphate 
Protected 4-Se-uridine nucleoside (4, 20 mg), tributylammonium pyrophosphate (2 eq.) 
and proton-sponge (2 eq.) were weighted and dried in individual flasks under high vacuum for 3 
hours and then filled with argon gas. Trimethyl phosphate (0.4 mL) was added into the flask that 
containing compound 4 and the flask was stirred in an ice bath. Later a solution of proton-sponge 
dissolved in trimethyl phosphate (0.3 mL) was injected into the solution of 4 at 0 oC. After 10 
min stirring, a pre-diluted phosphorus oxychloride (POCl3; 9 mL, 2 eq.) in trimethyl phosphate 
(90 mL) was added dropwisely into reaction mixture at 0 oC. The reaction was monitored by 
TLC plate (isopropanol: ammonium hydroxide: water; v 5:3:2) and was completed in 2 hours. 
Then tributylammonium pyrophosphate (2 eq., dissolved in 0.2 mL tributylamine and 0.4 mL 
DMF) was fast injected into the reaction mixture at 0oC and allows the reaction vigorously to stir 
for 5 min. Later the reaction was quenched with water (3 mL) and stirred for another 1 hr at the 
room temperature and monitored by TLC plate. To obtain crude compound 5, a sodium chloride 
(NaCl) solution (3 M NaCl, 0.5 mL) was added to the reaction flask, followed by adding pure 
ethanol (14.5 mL) and freezing the suspension at -80 oC for 1 hr to allow the crude product to 
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precipitate. Crude compound 5 was recovered by centrifugation for 20 min at 14,000 rpm in a 
falcon tube (50 mL). The 4SeCH2CH2CNUTP (5) pellet was re-dissolved in water, then analyzed and 
purified by HPLC. Pure 4SeCH2CH2CNUTP (5) was later characterized by NMR (1H-, 13C- and 31P-
NMR) and ESI-TOF analyses. 1H-NMR. The deprotection of compound 5 was carried out in a 
potassium carbonate (K2CO3) solution in methanol (6 eq.) at room temperature and monitored by 
TLC plate. After the reaction was complete, a NaCl/EtOH precipitation (described previously) 
was performed to obtain the compound 6 (strong yellow color). Later the pure 4SeUTP (6) was 
characterized by NMR (1H-, 13C- and 31P-NMR) and ESI-TOF analyses. Compound 5: 1H NMR 
(400 MHz, D2O) δ 8.11 (d, J = 7.1 Hz, 1H, H-5), 6.85 (d, J = 7.1 Hz, 1H, H-6), 5.85 (s, 1H, H-1′), 
4.45 – 3.97 (m, 5H, H-2′, H-3′, H-4′, H-5′), 3.34 (t, J = 6.8 Hz, 2H, CH2-CN), 3.12 – 2.92 (m, 2H, 
CH2-Se). 13C NMR (101 MHz, MeOD) δ: 177.04 (C-4), 154.40 (C-2), 139.75 (C-6), 119.56 
(CN), 107.60 (C-5), 89.56 (C-1′), 81.73 (C-4′), 73.77 (C-2′), 67.34 (C-3′), 63.08 (C-5′), 18.81 
(CH2CH2CN), 17.31 (CH2-CN).  31P NMR (162 MHz, D2O) δ -10.65 (d, J = 19.8 Hz), -11.51 (d, 
J = 20.1 Hz), -23.28 (t, J = 20.0 Hz). Compound 6: 1H NMR (400 MHz, D2O) δ 7.85 (d, J = 7.4 
Hz, 1H, H-5), 6.87 (d, J = 7.4 Hz, 1H, H-6), 5.81 (d, J = 3.7 Hz, 1H, H-1′), 4.31 – 4.20 (m, 5H , 
H-2′, H-3′, H-4′, H-5′). 13C NMR (101 MHz, D2O) δ 191.58 (C-4), 154.15 (C-2), 134.45 (C-6), 
117.10 (C-5), 88.96 (C-1′), 81.69 (C-4′), 73.31 (C-2′), 67.90 (C-3′), 56.43 (C-5′). 31P NMR (162 
MHz, D2O) δ -9.99 (d, J = 19.3 Hz), -11.54 (d, J = 20.2 Hz), -23.15 (t, J = 20.1 Hz). 
 
4.2.1.3 HPLC and UV analyses of 4SeCH2CH2CNUTP and 4SeUTP 
The crude 4SeCH2CH2CNUTP (4) was precipitated from reaction mixture after synthesis and 
directly purified by reverse-phase high-performance liquid chromatography (RP-HPLC). The 
purified 4SeCH2CH2CNUTP was characterized by NMR (1H, 13C and 31P), MS, HPLC and UV (Figure 
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4.1.1). For the preservative purposes, the major potion of 4-selenouridine-triphosphate is kept in 
the protected form (compound 4). Before transcription, 4SeCH2CH2CNUTP (4) was treated with 
K2CO3 (0.05 M in methanol) and was later precipitated with NaCl (3M) and ethanol, the pure 
4SeUTP is obtained. The maximal UV absorbance of native uridine triphosphate is 260 nm, the 
maximal UV absorbance of the 4SeU-triphosphate is 306 nm and the maximal UV absorbance of 
the 4SeU-triphosphate is 365 nm and the compound itself is strong yellow color (Figure 4.1.1). In 
the HPLC analysis, the native and selenium-modified UTPs were monitored with three 
wavelengths (260, 310 and 360 nm with a buffer gradient of 100% buffer A (20 mM 
triethylammonium acetate in water) to 25% buffer B (20 mM triethylammonium acetate in 50% 
acetonitrile and 50% water) in 20 min. The HPLC and UV profiles are shown in Figure 4.1.1 and 
Figure 4.2.1. The retention times of the native UTP, 4SeCH2CH2CNUTP and 4SeUTP were 11.3, 17.8 
and 14.7 min, respectively. 
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Figure 4.2.1. HPLC analyses of 4SeCH2CH2CNUTP and 4SeUTP at multiwavelength (260 nm, blue; 
310 nm, red; 360 nm, green).  
A) a1: Native UTP (retention time: 11.3 min); b1: 4SeCH2CH2CNUTP (retention time: 17.8 min); c1: 
co-injection of both native UTP and 4SeCH2CH2CNUTP (retention time: 11.3 min and 17.8 min). B) 
a2: Native UTP (retention time: 11.3 min); b2: 4SeUTP (retention time: 14.7 min); c2: co-injection 
of both native UTP and 4SeUTP (retention time: 11.3 min and 14.7 min). 
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4.2.2 4-Se-RNAs transcription 
 
Figure 4.2.2. The ribozyme time course experiments.  
A) The auto-radiography gel imagine of in vitro transcription with both native and 4SeU-RNA 
under same experimental conditions; (left): transcription of the native RNA (mutant 
hammerhead-ribozyme: MHR) with all native NTPs; the minor faster-moving band is the self-
cleaved product (fragment); (right): transcription of the 4SeU-MHR with SeUTP and other native 
NTPs. B) In vitro transcription of 4SeU-RNA under optimized conditions; (left): transcription of 
the native RNA with all native NTPs under standard condition; (right): transcription of the 4SeU-
MHR with SeUTP and other native NTPs under optimized conditions. 
 
 
To examine the 4SeUTP compatibility with RNA polymerase in transcription, the 
linearized plasmid templates for the crippled mutant hammerhead-ribozyme (MHR) were used 
(Figure 4.1.2). The transcription result shows that T7 RNA polymerase can recognize 4SeUTP 
(Figure 4.2.2A) and the transcript RNA contains 15 selenium atoms incorporation. Under the 
same experimental conditions, the transcription of 4SeUTP yields less product compare to the 
native one. To increase the 4SeU-RNA transcription yield, series of optimization experiments 
were carried out including buffer pH adjustment and 4SeUTP concentration alternation (Figure 
4.2.5). From the result, we have observed that with higher 4SeU-RNA concentration (4 times 
higher than native UTP) at pH 7.5, the transcription yield of Se-modified RNA is comparable to 
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the corresponding native RNA. The time-course experiments of both the native and 4SeU-
modified mutant ribozymes were performed using the mutant hammerhead-ribozyme template. 
The experiments are carried out under the same transcription condition as well as optimized 
transcription conditions for comparison (Figure 4.2.2). Although the transcript hammerhead 
ribozyme are mutant, partially self-cleaved fragment was still observed (minor faster-moving 
band). Detailed experimental condition was discussed in materials and methods. This result 
indicates that in the enzymatic catalysis, 4SeUTP does not cause significant interference. 
4.2.2.1 Transcription analysis of the 4-Se-RNAs 
The transcription experiment was carried out by following the standard procedures from 
the manufacturer, Epicentre (AmpliScribe™ T7-Flash™ Transcription Kit). α-32P-ATP was used 
as the radioactive labeling material for transcription experiments. Each transcription reaction (5 
μL) contained ATP, CTP, GTP and UTP (0.5 mM each) or 4SeUTP (2 mM for optimization), 
linearized plasmid DNA template (50 ng/μL), DTT (10 mM), transcription buffer (1x) for T7 
RNA polymerase, T7 RNA polymerase (10 U), and RNase-free water. At each time point of the 
time-course experiments, a gel loading dye (5 μL) containing 100 mM EDTA was added to 
quench the reaction, later the experiment was analyzed by denaturing PAGE (15% gel) and 
autoradiography. The translated RNAs were MHR (Figure 4.1.2). To conform the integrity of 
modified RNA, we transcribed an active self-cleavage RNA by using a linearized plasmid 
template of wild-type hammerhead ribozyme (WHR, Figure 4.1.2). This transcribed RNA 
contained 13 selenium atoms and unlike the MHR RNA, this WHR provides a clean cleaved 
RNA product (Figure 4.2.3A), the integrity of WHR was confirmed by MALDI-TOF MS 
analysis (Figure 4.2.3B).   
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Figure 4.2.3. Wild-type ribozyme transcription. 
(A)Wild-type native and 4-Se-modified ribozyme transcription with self-cleavage activity during 
synthesis. (B) MALDI-TOF MS analysis of the SeU-WHR (molecular formula: 
C543H672N218O385P56Se13); matrix: 3-hydroxypicolinic acid (3HPA, molecular formula: C6H5NO3); 
mass of SeU-WHR and six matrix observed: 20010 (calc. 20010.6). 
 
4.2.2.2 pH titration curve of 4-selenouridine 
The 4-selenouridine solutions were adjusted to desired pH values in the buffer of 50 mM 
Na2HPO4 at room temperature. The UV–Vis spectra were recorded every 0.1 pH unit between 
pH 6–8 and every 0.2-0.5 pH unit between pH 4–6 and pH 8–10. The pH of each solution was 
measured before and after its UV–Vis spectrum collection and the error was within ±0.02 pH 
unit. The titration data was plotted and shown in Figure 4.2.4. 
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Figure 4.2.4. Plot of wavelength (nm) versus pH for 4-selenouridine triphosphate.  
The fitted titration curve yields the pKa value (7.85±0.02). 
 
4.2.2.3 Transcription optimization of 4SeU-RNA 
With standard transcription condition, the transcription yield of 4SeU-RNA is lower than 
native RNA (Figure 4.2.2A). To reach the native transcription level, optimization experiments 
were carried out under different conditions. In the optimization experiments, we chose the 
linearized plasmid template to transcibe mutant hammerhead ribozyme (Figure 4.1.2A) that 
incorporates fifteen 4SeUTPs. We examined the transcription with different buffer pH values first 
since the acidity of the imino group (3-NH) of 4SeUTP varies with the selenium modification (pKa 
= 7.85, Figure 4.2.4). Eight transcription buffer pH were tested (pH 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5 
and 9.0), the buffer pH was adjusted by adding concentrated HCl into the solution, the buffer 
solution also includes 40 mM tris base, 6 mM MgCl2, 2 mM spermidine and 10 mM DTT. The 
best yield comes from buffer pH 7.5 (Figure 4.2.5A), the standard native buffer condition is pH 
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7.9. Under this optimized condition (buffer pH 7.5), higher concentrations of 4SeUTP were also 
examined and the transcription yield reached native transcription level when four times 
concentration of 4SeUTP was applied (Figure 4.2.5B). Later, this optimized condition with 
transcription buffer pH 7.5 and higher 4SeUTP concentration (4X) was applied to optimized 
transcription time course experiment (Figure 4.2.2B) and catalytic activity studies (Figure 4.2.6). 
 
Figure 4.2.5. Experimental results of transcription optimizations with 4SeUTP.  
A) Optimization with different transcription buffer pH (5.5 to 9.0), standard transcription buffer 
is pH 7.9. B) Optimization with different 4SeUTP concentration (0.2 mM to 2.0 mM), UTP 
concentration in native control is 0.5 mM. 
 
4.2.2.4 Catalytic activity analysis of the Se-RNAs 
The active hammerhead ribozymes with the sequence of 5’-
GGCAACCUGAUGAGGCCGAAAGGCCGAAACGUACA-3’ (Figure 4.1.2) is used in the 
catalytic experiments. The transcription of both native and 4-Se-RNA used in this experiment 
containing ATP, CTP, GTP and UTP (2.5 mM each) or 4SeUTP (10 mM for optimization), 
linearized plasmid DNA template (50 ng/μL), DTT (10 mM), transcription buffer (1x) for T7 
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RNA polymerase, T7 RNA polymerase (20 U), and RNase-free water. The template used in this 
transcription was a 55-nt long DNA duplex synthesized through solid-phase synthesis (5'-
TGTACGTTTCGGCCTTTCGGCCTCATCAGGTTGCCTATAGTGAGTCGTATTACGC-3' 
and its complimentary sequence). The transcription reaction was performed at 37oC for 2 hours. 
After transcription, the ribozymes were isolated from the template and primer. To compare 
catalysis activity, both the native and 4-Se-ribozymes were adjusted to same concentration 
(measured by UV). For ribozyme digestion experiment, a RNA substrate (5'-
ACCUGUACGUCGUUGCCUAA-3’) was synthesized through solid-phase synthesis (Figure 
4.1.2) and was purified. In order to monitor the transcribed ribozyme catalytic activity, the 
substrate was kinased with γ-32P-ATP at 5’ end by T4 polynucleotide kinase and the result was 
observed by gel analysis and autoradiography. After ribozyme digestion, the RNA substrate was 
cleaved and two fragments were obtained (11-nt and 9-nt in length respectively), but only the 5’-
32P-labled end (11-nt) was visible by autoradiography. The digestion time-course analysis was 
shown in Figure 4.2.6. 
 
Figure 4.2.6. The transcription of the wild-type native and 4SeU-modified ribozymes.  
Time-course of a 5’-32P-labled RNA substrate digestion by non self-cleaving native and 4SeU-
modified ribozymes under same enzyme and substrate concentration. The experiments were 
carried out at room temperature with 10 mM Mg2+ concentration. The pure RNA substrate is 
used as the comparing marker. 
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5     CONCLUSIONS 
In summary, the atom-specific mutagenesis has been extensively applied in RNA 
function and structure investigations, catalysis analysis, mechanism studies, as well as 
therapeutics discoveries. The great advantage of the single-atom replacements is that they may 
not only drastically improve beneficial properties of RNAs, such as thermostability and nuclease 
resistance, but also preserve RNA structure integrity without significant alteration. The atom-
specific modifications have indeed become a very convenient and practical strategy in the 
fundamental research of nucleic acids, including structural and functional studies and drug 
development. The selenium modifications in nucleic acids focus on the facilitation of 
crystallization and phasing in X-ray crystallography for structure determination of nucleic acids, 
nucleic acid–protein complexes, and nucleic acids complexed with small molecules as well as 
metal ions. In addition to the crystal structure study, the selenium derivatization can facilitate 
function studies, drug discoveries, and material investigations. 
We have first synthesized the SeU-phosphoramidite, SeU-triphosphate (2SeUTP and 4SeUTP) 
as well as SeU-RNAs. Our biophysical and structural studies on the SeU-RNAs indicate that the 
native and Se-modified structures are virtually identical. The 2-Se-modification can largely 
discriminate against the U/G wobble pair without significant impact on U/A pair, thereby 
providing a unique chemical strategy to further enhance base pair fidelity. The Se-modification 
will also provide a useful tool in X-ray crystal structure studies of RNAs and their protein 
complexes. Moreover, we have demonstrated that the synthesized SeUTPs (2SeUTP and 4SeUTP) 
are stable and recognizable by T7 RNA polymerase. Under the optimized conditions, the 
transcription yield of SeU-RNA can reach up to 85% of the corresponding native RNA. 
Furthermore, the transcribed SeU-hammerhead ribozyme has the similar activity as the 
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corresponding native, which suggests usefulness of SeU-RNAs in function and structure studies 
of noncoding RNAs, including the Se-tRNAs. The atom-specific mutagenesis with selenium 
opens a new research avenue for investigating base-pair recognition, fidelity and RNA 
modification. This novel base pair (SeU/A) with higher specificity likely enables better 
preservation of genetic information at the RNA level. 
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APPENDICES 
APPENDIX 1. Nucleic Acid Mini Screen contains twenty-four unique reagents from Hampton 
Research. 
 
 
  
Tube
#
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
                   Precipitant
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
              Polyamine
0.020 M Hexamine cobalt(III) chloride
0.020 M Hexamine cobalt(III) chloride
0.020 M Hexamine cobalt(III) chloride
0.020 M Hexamine cobalt(III) chloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
      Monovalent Ion
None
0.080 M Sodium chloride
0.012 M Sodium chloride,
0.080 M Potassium chloride
0.040 M Lithium chloride
0.080 M Potassium chloride
0.080 M Potassium chloride
0.080 M Sodium chloride
0.080 M Sodium chloride
0.080 M Sodium chloride, 
0.012 M Potassium chloride
0.012 M Sodium chloride, 
0.080 M Potassium chloride
0.080 M Sodium chloride
0.080 M Potassium chloride
None
0.080 M Potassium chloride
0.080 M Potassium chloride
0.080 M Sodium chloride
0.080 M Sodium chloride
0.080 M Sodium chloride, 
0.012 M Potassium chloride
0.012 M Sodium chloride, 
0.080 M Potassium chloride
0.080 M Sodium chloride
0.080 M Potassium chloride
0.040 M Lithium chloride
0.040 M Lithium chloride
None
Nucleic Acid Mini Screen™ HR2-118  Reagent Formulation
                    Buffer ¡
0.040 M Sodium cacodylate trihydrate pH 5.5
0.040 M Sodium cacodylate trihydrate pH 5.5
0.040 M Sodium cacodylate trihydrate pH 5.5
0.040 M Sodium cacodylate trihydrate pH 5.5
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0
Tube
#
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
Tube
#
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
Tube
#
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
      Divalent Ion
0.020 M Magnesium chloride hexahydrate
0.020 M Magnesium chloride hexahydrate
None
0.020 M Magnesium chloride hexahydrate
0.020 M Magnesium chloride hexahydrate
None
0.020 M Magnesium chloride hexahydrate
None
0.020 M Magnesium chloride hexahydrate
None
0.020 M Barium chloride
0.020 M Barium chloride
0.080 M Strontium chloride hexahydrate
0.020 M Magnesium chloride hexahydrate
None
0.020 M Magnesium chloride hexahydrate
None
0.020 M Magnesium chloride hexahydrate
None
0.020 M Barium chloride
0.020 M Barium chloride
0.080 M Strontium chloride hexahydrate, 
0.020 M Magnesium chloride hexahydrate
0.080 M Strontium chloride hexahydrate
0.080 M Strontium chloride hexahydrate, 
0.020 M Magnesium chloride hexahydrate
Tube
#
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
Nucleic Acid Mini Screen contains twenty-four unique reagents.  
To determine the formulation of each reagent, simply read across the page.
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APPENDIX 2. 1H NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-thiouridine 6. 
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APPENDIX 3. 13C NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-thiouridine 6. 
 
 
85 
 
APPENDIX 4. HRMS (ESI-TOF) of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-thiouridine 
6. 
 
 
 
  
11:02:1703-Feb-201050%MeOH+0.1%HCOOH, LeuEnk as ITSD  554.2615 Da
m/z
548 550 552 554 556 558 560 562 564 566 568 570 572 574 576
%
0
100
HUIYAN_SUN_5'DMTR_U2S_HRMS_ESI_NEG_HUANG_02032010 107 (1.991) AM (Cen,4, 80.00, Ar,5000.0,554.26,0.70); Sm (SG, 2x3.00); Cm (73:129) TOF MS ES- 
4.43e4561.1718
*
554.2615
559.3153
562.1750
563.1725
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APPENDIX 5. 1H NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-
methylthiouridine 7.
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APPENDIX 6. 13C NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-
methylthiouridine 7. 
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APPENDIX 7. HRMS (ESI-TOF) of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-
methylthiouridine compound 7. 
 
 
 
  
100%MeOH+0.1%HCOOH, Leuink as ITSD 18:12:35  17-Sep-2010
m/z
535 540 545 550 555 560 565 570 575 580 585 590 595 600 605 610
%
0
100
HUIYAN_2_S_U_1_HUANG_HRMS_ESI_POS_091710_01 120 (2.233) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Sm (SG, 2x3.00); Cm (120:141) TOF MS ES+ 
3.28e4577.2003
*
556.2771
551.3559
546.3981
542.4259 567.3516
595.3790
590.4229
601.3177 605.3292 611.3212
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APPENDIX 8. 1H NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-selenouridine 
8. 
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APPENDIX 9. 13C NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-selenouridine 
8. 
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APPENDIX 10. HRMS (ESI-TOF) of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-
selenouridine. 
 
 
APPENDIX 11. HRMS (ESI-TOF) of compound 9a and 9b. 
 
100%MeOH+0.5%NH4OH, Leuink as ITSD 17:23:44  01-Nov-2010
m/z
599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621
%
0
100
HUIYAN_2_SE_U_HRMS_HUANG_ESI_NEG_110110 8 (0.149) AM (Cen,4, 80.00, Ar,5000.0,554.26,0.70); Sm (SG, 2x3.00); Cm (8:20) TOF MS ES- 
2.55e3609.1136
607.1158
605.1223
599.5347 603.1392
608.1210
610.1281
611.1226
612.1277
613.1365
11:14:3303-Feb-201050%MeOH+0.5%NH4OH, LeuEnk as ITSD  554.2615 Da
m/z
711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741
%
0
100
HUIYAN_SUN_2SE)2'_TBDMS_HRMS_ESI_NEG_HUANG_02032010 76 (1.408) AM (Cen,4, 80.00, Ar,5000.0,554.26,0.70); Sm (SG, 2x3.00); Cm (5:85) TOF MS ES- 
1.01e4723.1990
721.1992
720.2026
719.2021
722.2031
724.2017
725.2001
726.2047
727.2040
739.1891
92 
 
APPENDIX 12. 1H NMR spectra of 1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-D-
ribofuranosyl)-2-cyanoethylselanyluridine 10a. 
 
 
93 
 
APPENDIX 13. 13C NMR spectra of 1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-D-
ribofuranosyl)-2-cyanoethylselanyluridine 10a. 
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APPENDIX 14. 1H NMR spectra of 1-(3’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-D-
ribofuranosyl)-2-cyanoethylselanyluridine 10b. 
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APPENDIX 15. 13C NMR spectra of 1-(3’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-D-
ribofuranosyl)-2-cyanoethylselanyluridine 10b. 
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APPENDIX 16. HRMS (ESI-TOF) of 1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-
D-ribofuranosyl)-2-cyanoethylselanyluridine 10a. 
 
 
 
APPENDIX 17. HRMS (ESI-TOF) of 1-(3’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-
D-ribofuranosyl)-2-cyanoethylselanyluridine 10b. 
 
 
16:31:5612-Feb-201050%MeOH+0.1%HCOOH, LeuEnk as ITSD  556.2771Da
m/z
770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787
%
0
100
HUIYAN_SUN_SECN_UP_HRMS_ESI_POS_HUANG_021210 165 (3.070) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Sm (SG, 2x3.00); Cm (158:165) TOF MS ES+ 
633778.2464
776.2532
775.2579
774.2406
772.5355
777.2489
779.2567
780.2577
781.2505
16:40:4112-Feb-201050%MeOH+0.1%HCOOH, LeuEnk as ITSD  556.2771Da
m/z
765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792
%
0
100
HUIYAN_SUN_SECN_DOWN_HRMS_ESI_POS_HUANG_021210 55 (1.022) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Sm (SG, 2x3.00); Cm (37:57) TOF MS ES+ 
5.87e3778.2401
776.2449
775.2399
774.2390
772.5201
777.2455
779.2433
780.2423
781.2444
790.3824
782.6303
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APPENDIX 18. 1H NMR spectra of 1-[2’-O-tert-butyldimethylsilyl-3’-O-(2-cyanoethyl-N,N-
diisopropylamino) phosphoramidite-5’-O-(4,4’-dimethoxytrityl-beta-D-ribofuranosyl)]-2-
cyanoethylselanyluridine 11. 
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APPENDIX 19. 13C NMR spectra of 1-[2’-O-tert-butyldimethylsilyl-3’-O-(2-cyanoethyl-N,N-
diisopropylamino) phosphoramidite-5’-O-(4,4’-dimethoxytrityl-beta-D-ribofuranosyl)]-2-
cyanoethylselanyluridine 11. 
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APPENDIX 20. 31P NMR spectra of 1-[2’-O-tert-butyldimethylsilyl-3’-O-(2-cyanoethyl-N,N-
diisopropylamino) phosphoramidite-5’-O-(4,4’-dimethoxytrityl-beta-D-ribofuranosyl)]-2-
cyanoethylselanyluridine 11. 
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APPENDIX 21. HRMS (ESI-TOF) of 1-[2’-O-tert-butyldimethylsilyl-3’-O-(2-cyanoethyl-N,N-
diisopropylamino) phosphoramidite-5’-O-(4,4’-dimethoxytrityl-beta-D-ribofuranosyl)]-2-
cyanoethylselanyluridine 11. 
 
 
 
APPENDIX 22. MALDI-TOF MS of 2-Se-U 12mer (5'-AUCACCSeUCCUUA-3’) [M+H+]+ = 3740.3 
(calc. 3740.2). 
 
 
 
iin MeOH+0.1%HCOOH, leuink as ITSD 11:48:30  20-Aug-2010
m/z
969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991
%
0
100
HUIYAN_SUN_DIMER_ESI_POS_HRMS_HUANG_082010_01 355 (6.609) AM (Cen,4, 80.00, Ar,5000.0,906.83,0.70); Sm (SG, 2x3.00); Cm (294:428) TOF MS ES+ 
1.32e5978.3528
976.3577
975.3588
974.3578
971.3718969.8278 973.3752
977.3619
979.3605
980.3577
981.3561
991.4268982.3612 989.3894986.8543
199 9.0 260 2.8 320 6.6 381 0.4 441 4.2 501 8.0
Mass (m/z)
434 .8
0
10
20
30
40
50
60
70
80
90
100
%
 In
te
ns
ity
470 0 Refl ctor Sp ec #1M C[BP =  3740. 3, 45]
37
40
.3
37
37
.3
37
93
.2
36
60
.4
37
14
.3
37
96
.2
36
99
.3
35
64
.2
38
47
.2
101 
 
 
 
APPENDIX 23. MALDI-TOF MS of 2-Se-U 12mer (5'-AAUGCSeUGCACUG-3') [M+H+]+ = 3859.4 
(calc. 3859.3). 
 
 
 
 
APPENDIX 24. MALDI-TOF MS of 2-Se-U 8mer (5’-GUAUASeUAC-3’) [M+H+]+ = 2558.7 ( calc. 
2558.5). 
 
 
299 9.0 340 3.2 380 7.4 421 1.6 461 5.8 502 0.0
Mass (m/z)
278 .2
0
10
20
30
40
50
60
70
80
90
100
%
 In
te
ns
ity
470 0 Refl ctor Sp ec #1M C[BP =  3859. 4, 278]
38
59
.4
38
57
.4
37
95
.5
37
97
.5
38
55
.4
39
73
.5
37
79
.5
34
89
.5
39
10
.5
39
69
.4
38
47
.5
199 9.0 220 1.8 240 4.6 260 7.4 281 0.2 301 3.0
Mass (m/z)
1.5E+4
0
10
20
30
40
50
60
70
80
90
100
%
 In
te
ns
ity
470 0 Refl ctor Sp ec #1M C[BP =  258. 7, 1460 3]
25
58
.7
25
59
.7
25
56
.7
24
78
.8
25
97
.7
25
55
.7
25
98
.7
25
34
.7
24
96
.8
25
71
.7
26
13
.7
25
36
.7
24
93
.7
26
49
.7
25
77
.7
24
53
.7
102 
 
APPENDIX 25. 1H-NMR of 2SeUTP (with Na+ and triethylammonium as counter ions). 
 
 
 
103 
 
 
APPENDIX 26. 13C-NMR of 2SeUTP (with Na+ and triethylammonium as counter ions). 
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APPENDIX 27. 31P-NMR of 2SeUTP (with Na+ and triethylammonium as counter ions). 
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APPENDIX 28. Mass spectrum of 2SeUTP. Molecular formula: C9H14N2O14P3Se-. HRMS (ESI-
TOF): [M-H+]- = 546.8812 (calc. 546.8829). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50%MeOH+0.5%NH4OH 17:19:44  18-Jul-2011
m/z
540 542 544 546 548 550 552 554 556 558 560 562 564 566
%
0
100
HUIYAN_2SEUTP_07171011_HUANG_071811_HRMS_LEUINK AS ITSD 84 (1.563) AM (Cen,4, 80.00, Ar,5000.0,554.26,0.70); Sm (SG, 3x3.00); Cm (76:93)
1.38e4546.8812
544.8815
542.8859
554.2615
548.8819
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APPENDIX 29. 1H NMR spectra of 5’-O-4,4’-dimethoxytrity -4-cyanoethylselanyluridine.  
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APPENDIX 30. 13C NMR spectra of 5’-O-4,4’-dimethoxytrity -4-cyanoethylselanyluridine 
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APPENDIX 31. 1H NMR spectra of 4-cyanoethylselanyluridine. 
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APPENDIX 32. 13C NMR spectra of 4-cyanoethylselanyluridine. 
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APPENDIX 33. 1H-NMR of 4SeCH2CH2CNUTP (with Na+ and triethylammonium as counter ions). 
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APPENDIX 34. 13C-NMR of 4SeCH2CH2CNUTP (with Na+ and triethylammonium as counter ions). 
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APPENDIX 35. 31P-NMR of 4SeCH2CH2CNUTP (with Na+ and triethylammonium as counter ions). 
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APPENDIX 36. 1H-NMR of 4SeUTP (with Na+ and triethylammonium as counter ions). 
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APPENDIX 37. 13C-NMR of 4SeUTP (with Na+ and triethylammonium as counter ions). 
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APPENDIX 38. 31P-NMR of 4SeUTP (with Na+ and triethylammonium as counter ions). 
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APPENDIX 39. Mass spectrum of 4SeCH2CH2CNUTP. HRMS (ESI-TOF): [M-H+]- = 599.9092 (calc. 
599.9094). 
 
 
 
 
 
 
APPENDIX 40. Mass spectrum of 4SeUTP. HRMS (ESI-TOF): [M-H+]- = 546.8835 (calc. 
546.8829). 
50%MeOH 15:33:45  17-Aug-2012
m/z
590 592 594 596 598 600 602 604 606 608 610 612 614 616
%
0
100
HUIYAN_4SEUTP-D1_HUANG-ACCU_08-17-2012_ESI-NEG01 148 (1.581) AM (Cen,2, 80.00, Ar,5000.0,554.26,0.70); Cm (94:160)
1.03e3599.9092
597.9124
595.9134 601.9076
20x in 50%MeOH+0.5%NH4OH 14:57:48  14-Sep-2012
m/z
525 530 535 540 545 550 555 560 565 570 575 580 585 590
%
0
100
HUIYAN_4SEUTP-20120914_HUANG-ACCU_09-14-2012_ESI-NEG01 133 (1.405) AM (Cen,2, 80.00, Ar,5000.0,554.26,0.70); Cm (101:160)
1.21e4546.8835
527.8516
554.2615
568.8507557.8484
584.8386576.8364
